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GENERAL INTRODUCTION 
Monoclonal antibodies are used extensively in various fields of biology and medicine. 
Some important applications include the investigation of cellular mechanisms, the isolation of 
interferons, cancer research, clinical diagnosis and gene product analysis. The generation of 
monoclonal antibodies with specific catalytic functions is an emerging technology which 
combines the high specificities of antibodies with chemical catalysis. A broad range of 
chemical transformations have been successfully catalyzed by monoclonal antibodies. The 
rationale is to immunize mice with predicted transition state analogs in the hope that 
molecules which bind the analog preferentially will function analogously to known enzymic 
mechanisms when presented with substrate. By current estimates, the immune system of 
mammals, humans included, has the potential to generate at least 100 million different 
antibodies, each with a distinctive binding site. This capacity exists to protect the body from 
disease-causing microorganisms and toxins. 
However, current methods for generating monoclonal antibodies, which are entirely 
dependent on hybridoma technology, do not pro\ade adequate survey of the natural 
inmiunological repetoire and limits the number of catalysts which may be obtained. Successful 
expression of recombinant antibody molecules in bacterial systems has recently been 
accomplished. These prokaryotic systems satisfy all the criteria for assembly of functional 
antibody fragments. Libraries can be constructed and screened for a desired antigen binding 
activity in less than two weeks. This efficiency allows for the rapid isolation of rare catalytic 
antibodies in a form suitable for genetic manipulation and propagation. However, these 
techniques are limited by the ability to efficiently screen for potential catalysts. Efficient 
screening is required for rapid development of catalytic antibodies. An assay which is sensitive 
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enough to detect catalysis at very low concentrations of catalyst would clearly have great 
value in the development of improved catalysts by modification of any type of existing 
catalyst, or even for screening of natural enzymatic activities. 
Explanation of the dissertation organization 
This dissertation will be divided into three papers. Each paper contains a separate 
research topic and includes an introduction, a results and discussion section, an experimental 
section describing preparation of key compounds, and a conclusion. The numbering of tables, 
figures, and structure is independent for each section. In the first paper, methods and 
considerations for the generation of catalytic antibodies for peptide ligation will be discussed. 
The second paper will describe the development of a sensitive assay for the detection of 
coupling catalysts and the synthesis of useful biological linkers. Finally, the third paper will be 
devoted to the discussion of a collaborative project between myself, under the guidance of Dr. 
Alan Schwabacher and researchers in professor Jacob Petrich's group involving the use of 
biotinylated 7-azatiyptophan as a fluorescent probe of protein structure and dynamics. 
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PAPER I 
STUDIES ON ANTIBODY CATALYSIS OF 
PEPTIDE LIGATION 
4 
INTRODUCTION 
With the preparation of the first monoclonal antibodies, the doors to a vast number of 
biological applications were opened. This advance occured when Kohler and Milstein' 
demonstrated that it was possible to generate in vitro monoclonal antibodies; antibody 
molecules consisting of a single distinct molecular structure. The generation of large amounts 
of homogeneous antibodies of desired specificity reproducibly has greatly expanded the role of 
antibodies in biology and medicine. Monoclonal antibodies have since been used increasingly 
in medicine and biology as therapeutic and imaging agents. Recently, chemists have begun to 
utilize and study these receptors as both synthetic aids and to gain a deeper understanding of 
how nature's catalyst, the enzyme, can achieve its remarkable catalytic efficiency and 
selectivity. 
Antibodies, or immunoglobulins, are a class of protein and are the product of the 
immune system in vertebrates. They are produced through a series of cellular processes in 
response to a natural or synthetic molecule ranging in size from a few hundred amu to very 
large macromolecules such as proteins. Recently, x-ray crystallographic studies have provided 
structures of antibody molecules and have revealed the nature of antibody-antigen 
recognition.^ Antibodies are large proteins with molecular weights of about 150,000 for 
immunoglobulin G and they consist of four polypeptide chains; two identical heavy chains and 
two identical light chains. The combining site consists of approximately 110 amino acids of 
the heavy and light chains and is known as the variable region. Within this region are six 
loops, three on the heavy chain and three on the light chain. These loop segments are referred 
to as the hypervariable or complementarity determining regions and display a high degree of 
sequence variability which provides the basis for the diversity in the antibodies produced and 
for the specificity exhibited by a particular antibody molecule. 
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Antibodies bind molecules with dissociation constants ranging from 10"^ to 10"!'* 
The specificity of antibodies for their ligands can exceed that of the enzyme for their 
substrates. Pauling stated almost SO years ago that the fundamental difference between 
enzymes and antibodies is that enzymes selectively bind transition states while antibodies 
selectively bind ground states.'*^ This high selectivity is mandated by the environment in which 
they function; in living organisms. Without the exhibited high specificity, disastrous 
consequences would result as has been observed in the case of autoimmune disease. 
Their mmn function is to protect the organism from invading and potentially harmful 
molecules such as bacteria, viruses, emd parasites. Their high affinity and selectivity are 
essential in order to distinguish foreign material from the organism's own tissue. Antibodies 
achieve these essential traits in the same way that enzymes and other proteins do; through the 
appropriate positioning of amino acid functional groups to form a uniquely defined three-
dimensional binding site. These amino acid functional groups act to stabilize the antibody-
hapten complex through a large number of non-covalent interactions consisting of hydrogen 
bonding, van der Waats and electrostatic attractions, and hydrophobic interactions. The many 
appropriately positioned interactions result in complexes with binding strengths rivaling those 
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of covalent bonds. A good example is the avidin-biotin complex which has a dissociation 
constant of 10*'^ M. This corresponds to a diffusion controlled on rate giving a complex with 
a half-life of two years! 
The concept of utilizing antibodies for the catalysis of chemical reactions, a task which 
in vivo is performed by enzymes, was bom from Linus Pauling's postulate that enzymes 
achieve their catalysis, in part, through the preferential binding and stabilization of the 
transition-state in a chemical transformation. Indeed, many good inhibitors of enzymes have 
structures which resemble the transition-state for the reaction they catalyze. This being the 
case, it was reasonable to conclude that if an antibody could be elicited which could tightly 
bind one of these inhibitors or any other transition-state analog for that manner, it would also 
be capable of catalyzing the corresponding chemical reaction in a similar fashion.'^^ This 
theory was first brought to fruition in 1986 with the isolation of antibodies that could 
selectively catalyze the hydrolysis of carbonates and esters. 
Since that time, a number of other catalytic antibodies have been developed exhibiting 
a variety of enzyme-like mechanisms in addition to just transition-state stabilization. This 
mechanistic diversity arises from both the diversity of the immune response itself where 10^-
10^ different antibody molecules can be produced in response to an antigen and from the 
general strategies used to elicit antibodies. These strategies include the use of antibodies to 
stabilize negatively or positively charged transition states, the use of antibodies as entropie 
traps, and the generation of catalytic antibodies with catalytic groups or cofactors in their 
combining sites. 
One of the greatest advantages in the use of catalytic antibodies over enzymes is that 
they can be "custom made" to catalyze a desired reaction for which there is no known enzyme 
catalyst. From the sheer number of antibody molecules produced, catalysts can be obtained 
which catalyze the same reaction but with different selectivities or through different 
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mechanisms. Another advantage is that when using monoclonal antibodies derived from 
immortal hybridoma cells, catalytic antibodies can be obtained easily in gram quantities. 
Attempts to produce polyclonal catalytic antibodies have been made J however, they are much 
less desirable as it is more difficult to detect small amounts of enzyme contaminants and to 
determine the amount and source of the catalyst present. Also, since the mixture is likely to 
contain non-catalytic antibodies which bind substrate, study of reaction rates is more difficult 
as well. 
Antibody Production 
The most common procedure for the production of catalytic antibodies begins with the 
selection of an appropriate transition-state analog. An antibody elicited against such a 
molecule should lower the free energy of activation for the corresponding reaction by 
preferentially stabilizing the transition-state relative to reactants and products. Since 
transition-states are unstable high energy species, stable analogs must be used. When a 
reaction proceeds through a tetrahedral intermediate or transition-state, as in the case of 
hydrolysis or aminolysis reactions, a phosphorus atom can be substituted for the central 
carbon giving a stable analog. For other transition-state analogs more imaginative approaches 
are required which incorporate the required geometries, bond lengths, and bond polarizations 
present in the transition state. It should be kept in mind, however, that the analog may not 
necessarily need to be an exact model of the transition-state. This is an advantage of the 
immune system diversity where m»iy similar binding sites with subtle variations are produced. 
Once an appropriate transition-state analog has been synthesized, it must then be 
conjugated to a carrier protein to give the desired antigen.^ A carrier protein is required in 
order to have a structure large enough for the immune system to recognize. Usually keyhole 
limpet hemocyanin (KLH) or limulus polyphemus hemolymph (LPH) are used as carrier 
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proteins because they elicit a strong immunogenic response in mammals. The transition-state 
analog is coupled through covalent linkages to amino acid side chains in the protein. For best 
results there should be a spacer of 6-8 angstroms in length between the hapten and the 
protein. 
A preparation of the antigen in an equal mixture of buffer and complete Freunds 
adjuvant is then injected into mice. After 3-4 weeks the mice are bled and the antibodies 
contained in the serum are tested by enzyme linked immunosorbent assay for their ability to 
bind the hapten. The mice are given boost injections until antibodies showing strong binding 
to hapten are obtained. After a final boost, the spleen cells are taken and flised with myeloma 
cells in polyethylene glycol to form an immortal line of antibody producing hybridoma cells. 
The hybridoma cells are then cloned by a series of dilution and regrowth stages. After each 
cycle, the hybridoma supernatant must be checked to pinpoint those cells producing antibodies 
with the desired hapten affinity. Once a hybridoma has been cloned, it can then be injected into 
mice promoting the formation of a tumor which produces the desired antibody. One of the 
advantages to the use of catalytic antibodies is that the structural framework of all antibodies 
is conserved. Therefore, the desired antibodies can be purified through standard means which 
includes dialysis followed by ion exchange chromatography. 
To date, antibodies elicited to transition-state analogs have been demonstrated to 
catalyze a variety of reactions ranging ftom hydrolyses of carbonate, ester, and amide 
substrates to the Diels-Alder reactions and Claisen rearrangements. Following are some 
representative examples of catalytic antibody production and the strategies used to obtain 
them. 
The first examples of catalytic antibodies specific for transition-state analogs were 
elicited against tetrahedral, negatively charged phosphate and phosphonate transition-state 
analogs for the hydrolysis of carbonates and esters. 
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A number of factors were considered in the design of this first generation of catalytic 
antibodies. First, these reactions have been an object of interest to physical organic chemists 
for decades and are among the most thoroughly understood organic reactions. Second, the 
steric and electronic nature of the transition-state for these reactions is sufficiently different 
ftom substrate so that it should be possible to generate antibodies that selectively stabilize the 
high-energy transition-state. The features of these transition-state species are mimicked well 
by relatively stable phosphates and phosphonates, which were already known to be potent 
inhibitors of some acyl-transfer enzymes and as a result, were presumed to be good transition-
state analogs. The use of these "mechanism based" haptens was expected to induce antibody 
binding sites that are sterically and electronically complementary to the transition-state 
configuration. Antibodies specific for these haptens acted as catalysts with rate accelerations 
on the order of 10^ to 10^ over the uncatalyzed reactions. The antibodies followed classical 
Michaelis-Menten kinetics, displayed substrate specificity, and bound the transition-state 
analog considerably more tightly than substrate, consistent with the notion of transition-state 
stabilization. 
Schultz and coworkers have produced monoclonal antibodies which specifically bind 
the tetrahedral nitrophenyl phosphonate transition-state analogs 2 and 4, which catalyze the 
aqueous hydrolysis of the corresponding carbonates 1 and 3, respectively, with kinetics 
consistent with the Mechaelis-Menten rate expression. The antibody-catalyzed hydrolytic 
reactions displayed substrate specificity and were competitively inhibited by the corresponding 
phosphate or phosphonate transition-state analog. Preferential binding and stabilization of the 
transition-state arising from the attack of water on antibody-complexed substrate 1 and 3 
should result in a decrease of the free energy of activation for the reactions. In each case, the 
inhibition constant (Ki) is substantially lower than the corresponding Km of the substrate, 
suggesting that transition-state stabilization plays a role in catalysis. 
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Since these early experiments, more than twenty acyl transfer reactions have been 
catalyzed. The fact that these antibodies can carry out stereospecific hydrolyses of unactivated 
esters with an enantiomeric excess greater than 100 to 1 points to commercial applications of 
catalytic antibodies. These results are significant because at present there exists no general 
method for generating stereospecific esterolytic catalysts. 
As an example of their specificity and potential utility in developing therapeutic agents, 
antibodies against transition-state analog 5 were prepared to obtain catalysts for the hydrolysis 
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of the tripeptide ester 6 under basic conditions. The antibody-catalyzed hydrolyses were 50 to 
300 fold faster than reaction with hydroxide ion. With relatively large transition-state analogs 
such as tripeptide 5, the tetrahedral phosphonate probably contributes proportionally less to 
the overall binding energy of the hapten to the antibody and, consequently, the rate 
acceleration observed is less than those of antibodies raised to smaller transition-state analogs. 
Interestingly, all 18 antibodies (out of the 25 that bound the hapten) found to accelerate the 
hydrolysis of ester 6 were selective for the D-phenylalanine-containing diastereomer although 
a mixture of diastereomers was used to generate the antibodies. This is a phenomenon 
commonly observed in catalytic antibodies and is due to preferential stimulation of cells 
producing these D-phenylalanine specific antibodies. The antibodies also show a high degree 
of substrate specificity. 
While these examples certainly illustrate the potential application of antibodies for 
selective catalysis and provide interesting mechanistic insights into how enzymes perform their 
functions in vivo, they do not illustrate the synthetic capabilities of the catalytic antibody. 
To the synthetic chemist, reactions in which two molecules are joined together are of 
5 
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much more interest than the reverse reaction. Often it is necessary to carry out these 
conversions under mild conditions and with high selectivity and specificity. Catalysts which 
can fulfill these requirements are of great utility. Enzymes, which are among the most efficient 
catalysts known would be good candidates, however they have selectivities for particular 
substrates which presumably have been developed over thousands of years of evolution and 
are limited in the types of reactions which they can catalyze. Although they are increasingly 
being used in synthesis, the synthetic substrates must resemble the natural substrate for the 
enzyme. With the advent of the catalytic antibody, this limitation was overcome as custom-
made enzymes can now be produced for a wide variety of reactions. Only in recent years has it 
been discovered that antibodies and enzymes, which are geared toward reactions in aqueous 
solution, can also catalyze reactions in organic solvents through such techniques as 
solubilization in reverse micelles^ and immobilization on surfaces. These advances, along 
with the aforementioned properties, have made catalytic antibodies very attractive candidates 
as catalysts in organic synthesis. 
One particularly good example of the potential of catalytic antibodies in synthesis is 
the antibody catalyzed Claisen rearrangement of chorismic acid to prephenate. ^ This 
OH OH OH 
7 8 
OH 
9 
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thermal 3,3-sigmatropic rearrangement proceeds stereospecifically and occurs through an 
asymmetric chairlike transition-state in which the carbon-oxygen bond is substantially broken 
while carbon-carbon bond formation has not proceded to any appreciable extent. There is a 
naturally ocurring enzyme, chorismate mutase, for this transformation and Paul Bartlett had 
previously shown that the oxabicyclic derivative 9 was a potent inhibitor of the enzyme with a 
dissociation constant of 1.5 x '2 Hilvert and coworkers (and simultaneously but 
independently Schultz and coworkers) reasoned that if an antibody were formed against the 
inhibitor 9, it may catalyze the conversion through transition-state stabilization. This is indeed 
what they observed. ^ ^3,b one of the eight antibodies which bound the hapten was found to 
catalyze the Claisen rearrangement of 7 to 8, with initial rates consistent with Michaelis-
Menton kinetics. The antibody catalyzed reaction was found to be accelerated by a factor of 
10'* over that of the uncatalyzed unimolecular rearrangement (k^at/kimcat = 1 x lO^ at 10° C 
and pH 7.0). This is comparable to the rate of the enzyme catalyzed process which gave a 
kcat/kuncat value of 10^. The antibody was also stereoselective catalyzing the conversion of 
only the (-)-isomer of chorismate. Because the conversion of chorismate to prephenate is an 
essential step in the biological synthesis of aromatic amino acids in bacteria, this system offers 
the possibility of applying random mutagenesis and selection to the evolution of antibodies 
with improved catalytic efficiency. Ffilvert has shown that by replacing the gene encoding for 
the natural enzyme with one encoding for the antibody and allowing mutagenesis and selection 
to take place better catalysts were obtained. Bacterial cells with poorer performing catalytic 
antibodies died while those with improved activity thrived. 
Recently, Hilvert and coworkers have determined the crystal structure for one of their 
catalytic antibodies exhibiting chorismate mutase activity, The antibody (1F7) was 
crystallized as a complex with the transition state model 9 and its crystal structure was 
determined to 3 A resolution and compared with the structure of a naturally occuring 
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chorismate mutase from Bacillus subtilis also complexed to 9. This comparison provides an 
excellent opportunity for the determination of the factors are involved in antibody catalyzed 
reactions and of how they relate to the enzyme analogs. The types of contacts between 
antibody and 9 are similar to those observed for other antibody hapten interactions and were 
consistent with the types of interactions one would expect to observe from antibodies elicited 
against 9 such as an ion pair between ArgH95 and the C-11 carboxylate. Comparison with the 
structure of chorismate mutase illustrated some differences which may explain the higher rate 
accelerations by the enzyme and suggest ways of improving the catalytic efficiency of the 
antibody. 
The transition state for the conversion of chorismate to prephenate is a pseudodiaxial, 
highly polarized species and it was observed that the enzyme possessed two positively charged 
Arg residues in an area of the binding site near the C-11 carboxylate and a negatively charged 
Glu residue near the hydroxyl group at C-4. This arrangement effectively creates an 
electrostatic environment complimentary to the polarized transition state and may be one of 
the key factors in its stabilization. Also, it is conceivable that one or both of these side chains 
may participate directly in the reaction. These comparisons led to some suggestions for 
designing a transition state analog for the reaction that may lead to the formation of an 
antibody binding site which more closely resembles that of the enzyme. For instance if the C-4 
hydroxyl group is replaced by an ammonium ion it may elicit the production of a negatively 
charged Glu residue as is present in the enzyme. Examples such as this clearly provide a 
strong case for the use of antibodies both as catalysts and as a means of further studying 
enzyme catalysis. 
Another example of the use of antibodies to act as entropie traps involves the study of 
an antibody-catalyzed Diels-Alder reaction. This reaction, which has long been one of the 
most powerful transformations in synthetic organic chemistry, is a reaction between a diene 
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and an alkene giving rise to a cyclohexene product. The transition state for this reaction 
involves a highly ordered cyclic array of interacting orbitals in which carbon-carbon bonds are 
broken and formed in a single concerted mechanistic event. As a result, an unfavorable 
entropy of activation on the order of -30 to -40 eu is generally observed. The reaction product 
is not an appropriate hapten for generating catalytic antibodies since severe product inhibition 
would be expected to result. Therefore, the design of haptens that would lead to catalytic 
antibodies for this bimolecular reaction must not only make use of proximity effects but must 
also provide a mechanism for eliminating product inhibition. Hilvert and coworkers were 
successful in designing a hapten which satisfies both criteria. They reasoned that a stable 
analog of the bicyclic adduct could elicit an antibody combining site with the proper shape for 
promoting the target reaction. As the final product does not closely resemble the transition 
state of the reaction, product inhibition would be minimized, allowing multiple turnover of the 
catalyst. 
The particular reaction chosen was that of tetrachlorothiophene dioxide with N-
ethylmaleimide. They prepared five monoclonal antibodies that bound the hapten 11 which 
was a stable transition state analog of the bicyclic adduct 10. Of these antibodies, one 
catalyzed the formation of the initial Diels-Alder adduct which then spontaneously extrudes 
sulfur dioxide to give the secondary dihydrophthalimide product which is bound weakly by the 
antibody due its large structural differences relative to the transition state. This experiment, 
although requiring a somewhat unusual diene, provided the first report of a catalytic antibody 
for a useful chemical transformation and demonstrated the feasibility of utilizing antibodies in 
organic synthesis. 
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RESULTS AND DISCUSSION 
It is evident through the examples cited that antibody catalysts have been applied to a 
number of useful chemical transformations. However, although there are several examples of 
antibody-catalyzed amide bond formation'^"'^, no catalytic antibody has yet been produced 
which is capable of catalyzing peptide bond formation between specific amino acids - a 
reaction which would be extremely useful for peptide ligation. 
A common practice for the production of peptide chains is the use of the Merrifield 
peptide synthesis. In this procedure, peptide chains are built up one amino acid at a time by a 
series of coupling and deprotection steps. For shorter peptides, this method works very well 
as the entire process can be automated to produce the desired peptide. The procedure cannot 
however, be easily applied to the preparation of peptide chains longer than about twenty 
amino acid units due to the requirement for extremely high integrity in the coupling and 
deprotection steps. For example, even if every step proceeded with 99.9 percent completion, 
after twenty cycles there would be a 4 percent impurity, which for purposes of accurate 
characterization is unacceptable. The best strategy then, is to form the shorter peptide 
fragments using the Merrifield procedure and then to couple these fragments by another 
method. A coupling catalyst with high selectivity and efficiency would be ideal for this second 
method and we envisioned that a catalytic antibody would be very well suited to this role. As 
a result, we set out to produce a catalytic antibody with the desired peptide ligase ability and 
mth specificity for a peptide containing an N-terminal histidine residue. 
To achieve our goal, we designed and synthesized the phosphoramidate 17 as a 
transition-state analog for the desired reaction. In an aminolysis reaction between an amine 
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and an ester, a tetrahedral intermediate is formed and, based on the Hammond postulate, the 
transition-state for this reaction should have a similar structure. The overall reaction and 
intermediates are shown in Figure 1 below. By substituting phosphorus for the carbonyl 
carbon, a stable, tetrahedral model of the transition-state can be formed. The bonds being 
broken and formed are expected to be elongated in the transition-state and the analog 
R. ,0. 
. o 
H O 
Tetrahedral Intemiediate 
H o 
17 
Figure 1. Proposed coupling reaction and transition state analog 
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is also a good model in this respect as the phosphorus-oxygen and phosphorus-nitrogen bonds 
are slightly longer than the corresponding carbon-based bonds. The dinitrophenyl group on 
histidine is useful both as a protecting group for the imidazole nitrogen and as a means for 
eliciting a stronger antigenic response. The major difference between the phosphoramidate 17 
and the actual transition-state is that the latter is expected to have some zwiterionic character 
whereas 17 is neutral. Since both the substrate and the product contain planar sp^ carbon, the 
tetrahedral transition-state is expected to be bound preferentially in an antibody catalyzing the 
desired reaction. Although the analog is most closely correlated with aminolysis of a 
carbonate, catalytic antibodies for ester aminolysis are expected to be obtained due to the 
diversity of the immune response and the antibodies obtained. The free carboxylate on one of 
the phenyl groups serves as a connecting point to the carrier protein. 
Synthesis of the hapten 17 involved a convergent synthesis beginning with w-hydroxy 
benzoic acid and /-Boc-histidine. Benzyl m-hydroxybenzoate 12 was formed by treatment of 
the starting acid with one equivalent of KOH to produce the potassium salt which was then 
treated with benzyl chloride. The crude product was recrystallized from ether/hexanes to give 
the pure product in 72% yield. The bis(/n-benzyloxycarbonylphenyl) chlorophosphate 13 was 
prepared from two equivalents of benzyl m-hydroxybenzoate and one equivalent of 
phosphorus oxychloride in tetrahydrofuran by addition of an excess of pyridine. /-Boc-
histidine was treated with dinitrofluorobenzene in a one to one mixture of tetrahydrofuran and 
water containing sodium bicarbonate to obtain the Ni^-protected dinitrophenyl derivative 14 
which could be recrystallized from isopropanol in 89% yield. Refluxing this product in ethanol 
containing thionyl chloride caused simultaneous deprotection of the alpha amino group and 
formation of the ethyl ester. The ethyl ester (15) could then be purified further through 
recrystallization in methanol and tetrahydrofuran with a yield of 62%. 
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The chlorophosphate, prepared in situ, was then introduced to a solution of the 
histidine ethyl ester in tetrahydrofUran and triethylamine to form the phosphoramidate 16 
which could be purified on a silica gel column to obtain the product as a yellow oil in 52% 
yield. Finally, deprotection of the carboxylates with trimethylsilyl iodide in deuterochloroform 
afforded the diacid 17 which could then be purified by HPLC using a CIS column. 
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A sample of hapten was conjugated to KLH in order to obtain the desired antigen 17b. 
This was done through activation of the carboxylate function by formation of its NHS ester in 
acetonitrile followed by addition to a solution of KLH in pH 8.4 BBS. To purify the 
conjugate, a sephadex G-50 size exclusion column was used. 1.5 ml fractions were collected 
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using pH 7.4 PBS as eluent. Fraction 3 contained the largest protein concentration which was 
determined by BCA assay to be 1.5 mg/ml. 
The extent of conjugation was determined by either TNBS assay of free amines on the 
protein before and after coupling and/or by thiolysis of the dinitrophenyl group of the hapten 
by 0.4 M mercaptoacetic acid. The thiolysis reaction was carried out in pH 7.0 phosphate 
buffer under conditions worked out by D, V. Jewell who was an undergraduate student 
working under my direction. The thiolysis product mixture was extracted into ethyl acetate 
after acidification of the aqueous layer with sulfuric acid. A standard using /-Boc-(DNP)-
histidine was treated in the same manner. The residue was dissolved in HPLC eluent and 
components were then quantified by HPLC using an isocratic eluent of 1:1 acetonitrile ; 0.1% 
TFA/H2O and monitoring at 340 nm. Quantitation of the peak eluting between 5.0 and 5.4 
minutes, which corresponds to the dinitrophenyl mercaptoacetic acid, indicated that three to 
four haptens per protein were present. 
The procedures for conjugation of hapten to protein were the same when using BSA 
or LPH except that the hapten was in DMF solution when conjugated to BSA and the LPH 
conjugate was purified on a sephadex G-25 size exclusion column. 
A sample of the antigen was then given to the hybridoma service, headed by Dr. 
Richard Van Deusen, at Iowa State University. The hybridoma service proceeded to 
immunize mice with our hapten following techniques similar to those described in the 
introduction. Serum samples were then received from their laboratoiy approximately every 
four weeks. These samples were then screened by enzyme-linked immunosorbent assay for 
their ability to bind hapten. For this purpose, the hapten was conjugated to BSA protein in 
order to distinguish between samples binding hapten as opposed to the carrier protein. 
Specificity for the entire hapten as opposed to just the dinitrophenyl or dinitrophenylhistidine 
group was also checked by making BSA conjugates of these latter compounds. 
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ELISA of serum from mouse L indicated that it contained antibodies recognizing 
hapten. This sample gave a titer of640 when using hapten as Hgand and only 160 with the 
dinitrophenyl group as a ligand. This is significant since the dinitrophenyl group is such a 
strong antigenic determinant. The fact that binding was stronger to the whole hapten molecule 
rather than to its pieces indicates that antibodies recognizing other structural features such as 
the tetrahedral phosphorus are present. The antibody-producing spleen cells from this mouse 
were fused with myeloma cells to prepare hybridoma cells which would proliferate in the cell 
culture medium while both the unfUsed myeloma and spleen cells would die. As described in 
the introduction, the hybridomas were expanded in vitro and samples of the hybridoma 
supernatant were tested for their ability to bind hapten over other components of the antigen. 
Wells containing cells producing these antibodies were cloned by dilution in the Van Deusen 
lab until a purified line of hybridoma cell was obtained. 
Upon initial screening, samples labelled 2E5, 3E8, 3E10, 5C5, 7G4, 8F2, 10D2, and 
6C8 indicated that they could contain potential candidates for transition-state specific 
antibodies. Through the dilutions, however, many of the samples which had looked promising 
were evidently overgrown by non-antibody producing cells. The results are shown in Table 1. 
One sample which survived, labelled 3E10, had a hapten titer of 64, a dinitrophenyl titer of 8, 
and showed no binding to KLH. The cloned hybridoma cells, labelled 3E10;E3, were injected 
into mice to initiate an antibody-producing tumor. The ascites fluid from this tumor, which 
contained the antibody of interest, was taken for analysis. 
Any catalysis exhibited by this antibody was looked for both by the hydrolysis of 
substrates and by a catalytic assay described below. In a typical hydrolysis assay, a sample of 
the catalyst was introduced to a solution of dinitrophenyl histidine ethyl ester and bis(/n-
carboxyphenyl) carbonate 18 in pH 8.0 BBS. The extent of formation of w-hydroxybenzoate 
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Table 1. 
Results of immunization of mouse L with Hapten. 
Mouse L Serum 
KLH HaptenBSA DNP 
640 640 0 160 
Fusion Suoernatant; 
Initial Titer After Selection 
Well A/( JO Hapten DNP A,110 Hao DNP KLH Clone 
2E5 1.033 8 64 0 
3E8 0.910 8 0 
3E10 1.851 256 64 1.233 64 8 0 E3 
7G4 1.305 64 16 0 
8F2 1.734 64 16 0 
10D2 1.022 8 0 
6C8 1.200 256 8 0 
5D7 0.120 0.181 0 4 16 frozen 
6D8 0.132 0.142 2 0 4 N.B. 
5C5 0.226 0.241 2 4 0 N.B. 
was then monitored by HPLC. Following this procedure, no increase in production of m-
hydroxybenzoate was observed over the background hydrolysis in which no catalyst was 
added. 
The steps required to maintain, clone, and purify large amounts of a particular 
antibody are costly in terms of both time and money. Oftentimes it is found that the best 
catalytic antibodies are not necessarily those that bind the hapten with the highest affinity. In 
some cases potential catalysts for a desired reaction may be overlooked simply because they 
did not bind the expected transition-state analog tightly enough. These antibodies may achieve 
catalysis through a mechanism other than simple transition-state stabilization and in many 
cases lead to interesting insights into the way enzymes have come to perform their catalytic 
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roles. Therefore, instead of the standard protocol of screening antibody samples for their 
ability to bind hapten, it would also be desirable to screen these antibodies directly for 
catalytic activity. Preferably this catalytic screening would be carried out as early as possible 
after hybridoma cells had been prepared. Hilvert and coworkers have done this in identifying 
catalytic antibodies for the decarboxylation of benzisoxazole-3-carboxylate ions to yield 2-
cyano-5-nitrophenol which could easily be detected by UV-Vis spectroscopy. The problem 
to date is that no general assay exists for this purpose. A major reason for this is that antibody 
catalysts produced in hybridoma supernatant are present in very small amounts and this 
requires an extremely sensitive assay. Once antibody-rich ascites fluid is obtained, standard 
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analysis techniques such as HPLC or NMR can be used to determine their reaction rates but 
such techniques are not applicable to the screening of hybridoma supernatant. 
To address this problem, we had envisioned an assay which is similar in practice and 
sensitivity to the enzyme linked immunosorbent assay and can be of general utility in finding 
coupling catalyts for a variety of reactions. In order to detect the antibodies with peptide 
ligase ability, as was the goal of our attempt to obtain catalytic antibodies, we covalently 
attached one substrate for our antibody (the dinitrophenyl histidine moiety) to BSA. This 
substrate could then be fixed to a hydrophobic surface by binding of the BSA to which it was 
attached. The second substrate which is an w-carboxyphenyl ester was then labelled with 
biotin through an amino caproic acid spacer arm. 
To detect catalytic activity, a solution of the biotin-labelled w-carboxyphenyl ester 20 
and the hybridoma supernatant sample were placed in a microtiter plate well containing the 
surface bound dinitrophenyl histidine substrate 19. Amide bond formation would result in the 
linkage of the biotin tag to the surface. After rinsing away excess reagents, the biotin molecule 
could be detected through visualization using streptavidin-horseradish peroxidase and 3-ethyl-
2-azino benzthiazoline sulfonate (ABTS). Streptavidin binds biotin very tightly with a 
dissociation constant of 10"^^ M. The attached peroxidase can then be used to convert the 
colorless ABTS into its intensely green colored oxidation product. By monitoring absorbance 
at 415 nm the extent of reaction can then be quantitated. 
Carrying out this assay on our.supematant samples, we found one candidate, 5C5, to 
show some absorbance above the control reaction containing no catalyst. Although these 
results were observed by both myself and my assistant David Jewell, they were unfortunately 
not reproduced in subsequent trials and it could therefore not be known with certainty 
whether 5C5 was actually catalytic. 
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One problem with applying this assay to the detection of catalysis in our antibody 
samples was that we were dealing with two unknowns. It was difficult therefore to work out 
appropriate conditions for the assay when it was uncertain that there was in fact a catalyst to 
detect. Another problem was that the solubility of the phenyl ester substrate in water was 
limited, which could have contributed to the variability in results observed. A more soluble 
version of a substrate would be desirable as well. At any rate, it was decided that working out 
assay conditions using a known catalyst would be highly desirable and the results obtained will 
be addressed in the following chapter. 
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CONCLUSIONS 
In this chapter, the considerations and methods required to produce catalytic 
antibodies have been discussed. These methods were followed closely in our attempts to elicit 
catalytic antibodies for an as yet unreported but useful peptide coupling reaction. Despite our 
efforts, catalytic antibodies were not obtained. The success of isolating catalytic antibodies 
hinges on the production and subsequent characterization of a large number of hapten-specific 
antibodies. For reasons which are difficult to determine, an unusually low number of hapten-
specific antibodies were obtained after the immunizations of eight mice by the hybridoma 
facility. Several possible explanations for this low number of antibodies were discussed in the 
preceding section. This is especially unusual in light of the fact that a dinitrophenyl group, 
which is known to be a strong antigen, was incorporated into the hapten structure. 
As for the hapten-specific antibodies which were detected in supernatant, many were 
overgrown before they could be cloned and purified. This was partly because of the lag time 
between sampling in one laboratory, screening in our laboratory, and cloning in the first. A 
faster turnaround is an important aspect of success in such projects. Since the catalytic assay 
did not indicate the presence of any catalysts, it was difficult to determine whether we had a 
working assay. For this reason, we turned to a study of a known catalyst in order to develop 
the assay as described in the following chapter. The one antibody that was obtained through 
ascites fluid did not show catalytic activity when screened by the methods described. 
Future attempts to form catalytic antibodies of this type may involve the use of 
combinatorial antibody libraries which must be screened to locate hapten-specific antibodies. 
In these instances, as well as in the conventional immunological methods, it will be important 
to quickly and sensitively locate the antibodies which exhibit catalytic properties. For this 
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reason, concentration was focused on the development of an assay for the general and 
sensitive detection of catalytic species as will be described in the following chapter. 
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EXPERIMENTAL 
General methods 
All infrared spectra were obtained on an IBM IR98 FT-IR spectrophotometer and all 
proton and carbon nuclear magnetic resonance spectra were obtained on a Nicolet NT-300 
NMR spectrometer, Chemical shifts are reported relative to tetramethylsilane (TMS) as an 
internal standard and the solvent is deuterochloroform unless otherwise noted. Coupling 
constants (J) are reported in Hz. High resolution mass spectral analyses were performed on a 
Kratos MS-SO spectrometer. Low resolution mass spectra were obtained from a Finnegan 
4023 mass spectrometer. Melting points were determined on a Fisher-Johns melting point 
apparatus and were uncorrected. Thin-layer chromatography (TLC) was performed on 
commercially prepared E. Merck silica gel 60F glass plates (0.25 mm) and flash 
chromatography was carried out as described by Still with the use of E. Merck Kieselgel 60 
silica gel (230-400 mesh). 
All of the chemicals used were directly obtained from commercial sources unless 
otherwise noted. Acetonitrile used for reactions was freshly distilled from P4O10. Methylene 
chloride and triethylamine were distilled from CaH2 and pyridine was also distilled from CaH2 
except for use in ninhydrin assays in which case it was distilled from ninhydrin. THF was 
distilled from potassium metal and benzophenone. 
Benzyl m-hydroxybenzoate (12) 
To a solution of /w-hydroxybenzoic acid (394 mg, 2.852 mmol) in 4 ml of EtOH was added 
KOH (168 mg, 2.995 mmol). The KOH dissolved, and after about 2 minutes, product 
precipitated. Solvent was removed by rotary evaporation, and then by azeotropic toluene 
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evaporation (2X5 ml). This crude potassium w-hydroxybenzoate was dissolved in DMF (1.8 
ml), and treated with benzyl chloride (348 mg, 3.023 mmol) and KI (23.6 mg, 0.143 mmol) at 
85-95''C for 1.5 hr, until starting material was consumed. (TLC 8% CH3CN / CH2CI2 UV, 
PMA: product Rf= .50, BnCI .88, salt 0). The reaction mixture was cooled to room 
temperature, diluted with EiiO, and washed three times with H2O and aqueous NaHCOg 
After drying over MgS04, solvent was removed on a rotary evaporator to give an oil which 
crystallized upon standing overnight on the vacuum pump. Recrystallization from 
ether/hexanes gave pure benzyl /w-hydroxybenzoate as reported in the literature (MP 69-70°C, 
423 mg, 65%) (Ut.20 MP = 70«>C). »H NMR (300 MHz, CDCI3) S = 5.34 (s, 2 H), 6.36 
variable (s, IH), 7.01-7.66 (m, 9H). FT-IR (cm'l, CDCI3) 3380(br); 3033; 2954; 1716; 1589; 
1455; 1289; 
1222; 754. 
bis (m-(benzyioxycarbonyl)phenyl) chlorophosphate (13) 
A solution of triethylamine (1.9ml, 14 mmol) in 10 ml of THF was added dropwise 
with stirring to a 0°C solution of benzyl wi-hydroxybenzoate (1.29g, 5.66 mmol) and freshly 
distilled phosphorus oxychloride (0.259 ml, 2.83 mmol) in 8 ml THF. The reaction mixture 
was allowed to warm to room temperature, and stirred for an additional 1 1/2 hours. The 
triethylamine hydrochloride salt was allowed to settle. Best results were obtained when the 
chlorophosphate reagent was not isolated, but instead measured volumetrically and transferred 
by syringe for subsequent reaction. Evaporation of solvent gave crude product. 'H NMR (300 
MHz, CDCI3) Ô = 5.38 (s, 2H), 7.43-7.37 (m, 6H), 7.49-7.54 (m, IH), 7.96 (t, J = 1.5 Hz, 
IH), 8.04 (t, J = 2.7 Hz, IH). 
32 
Not-/-Boc-Njm-DNP histidine (14) 
Na-/-Boc histidine (892.5 mg, 3.496 mmol) obtained from Sigma was dissolved in 10 
ml nanopure water along with 673.1 mg (7.991 mmol) sodium bicarbonate. Meanwhile, 2,4-
dinitrofluorobenzene (0.502 ml, 3.995 mmol) was dissolved in 10 ml THF in a separate 
container. After the histidine solution had been chilled to 0° C in an ice bath, the 
dinitrofluorobenzene/THF solution was added with stirring. The resulting solution was placed 
in a refrigerated chromatography cabinet maintained at 4° C and stirred for 6 1/2 hours. 
The solution was then washed with 60 ml ether, acidified to pH 2 with NaHSO^ and 
extracted with ethyl acetate (3 x 40 ml). The ethyl acetate solution was dried with sodium 
sulfate, filtered and solvent removed under vacuum to give a yellow oil. Carbon tetrachloride 
(15 ml) was added and evaporated off to remove other solvents. After removing solvent, a 
yellow-orange foam remained. 
The foam was then dissolved in refluxing isopropanol and cooled to room temperature 
after which time a large amount of solid product had recrystallized. The solid was broken up 
and mixed with carbon tetrachloride and filtered using carbon tetrachloride as the wash. After 
being placed on the vacuum pump for 6 hours, a NMR spectrum was taken which showed 
the product was present along with some isopropanol (9.1% by weight). The yield subtracting 
out the weight of isopropanol was 1.3096 g (3 .11 mmol) which corresponds to a 89% yield. 
TLC Rf = 0.8 (eluent = 15:3:2.5 MEK:Ac0H:H20) visualized by UV. FT-IR (CDCI3, cm"'): 
3370, 3110, 2955, 1711, 1608, 1544, 1500 iR NMR (300 MHz, CDCl3)Ô= 1.45 (s, 9H), 
3.12-3.43 (m, 2H), 4.47-4.60 (m, IH), 5.51 (d, J= 5.97 Hz, IH), 6.89 (s, IH), 7.78 (d, J = 
8.69 Hz, IH), 7.88 (s, IH), 8.60 (dd, Ji = 2.46 Hz, = 8.73 Hz, IH), 8.87 (d, J = 2.46 Hz, 
IH). M.P. = 98-1020c. Data were consistent with that previously reported^'. 
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(DNP) histidine ethyl ester (hydrochloride salt) (IS) 
Ethanol (12 ml) was chilled in an ice bath in a dry flask, and 0.178 ml (2.483 mmol) 
thionyl chloride was added with stirring. Next, 451 mg (1.080 mmol) ofNo^-Z-Boc-Nj^i-DNP 
histidine, which had been dried under vacuum, was added with stirring. The solution was 
refluxed and the solid dissolved. Refluxing was continued for 5 hours after which time a large 
amount of solid had precipitated from the refluxing solution. The mixture was filtered through 
a coarse filter glass funnel to collect the solid weighing 276.9 mg. Yield 66% (0.710 mmol). 
The product can be purified further through recrystallization from methanol and 
tetrahydrofiiran in a ratio of 3 to 1. TLC: Rf= 0.6 on silica gel using MEKiAcOH HgO in a 
ratio 15:3:2.5 as eluent and UV to visualize. MP = 210-212%. NMR (300 MHz, CD3OD) 
Ô = 1.31 (t, J = 7.1 Hz, 3H), 3.40-3.49 (m, 2H), 4.26-4.40 (m, 2H), 4.46 (t, J = 5.4 Hz, IH), 
7.81 (s, IH), 8.15 (d, J =8.71 Hz, IH), 8.78 (dd, J, = 2.43 Hz, J] = 8.74 Hz, IH), 9.11 (d, J 
= 2,46 Hz, lH)9.18(s, IH). 
Phosphoramidate (16) 
Dry toluene (4 ml) and trimethylsilyl chloride (100 ul, .788 mmol)) were added to 
Nim.DNP histidine ethyl ester (108.8 mg, 0.2813 mmol) and, after stirring for 35 min., were 
evaporated off Another 4 ml toluene was then added and removed under vacuum. 
A THF solution (5.0 ml) of the chlorophosphate (0.0469M, 0.233 mmol) was then 
added with stirring, followed by 0.25 ml triethylamine. 
After 2.5 hrs., an intense spot of Rf 0.33 was observed by TLC on silica gel with ethyl 
acetate as eluent. After 12 hrs., the reaction mixture was filtered on a coarse filtered glass 
funnel, washing with THF. A clear yellow filtrate was collected and solvent was removed 
under vacuum. The yellow oil remaining was flashed using ethyl acetate as eluent to give the 
desired phosphoramidate in 52% yield (88.5 mg). ^H NMR (300 MHz, CDCI3) Ô = 8.76(d, 
IH, J = 2.5), 8.48(dd, IH, J = 2.5, 8.7), 7.90-7.78 (m, 3H), 7.50-7.35(m, 16H), 6.79 (s, IH), 
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5.32 (d, 4H, J = 6.0), 4.59 (t, IH, J = 9), 4.49-4.39 (m, IH), 4.11 (q, 2H, J = 7.2), 3.18-2.96 
(abx, 2H, J = 4.6, 5.8, 14.6), 1.18 (t, 3H, J = 7.2). Mass Spectrum; DCI-NH3 M+ = 850, m/e 
= 849.75 (calculated for C42H36N5O13P). 
TMSI cleavage of benzyl esters to yield 17 
The phosphoramidate (22.4 mg, 0.0264 mmol) was dissolved in 1.0 mis CDCI3 which 
had been previously stored over 4A molecular sieves. The resulting solution was transferred 
to a dry NMR tube, which was then flushed with nitrogen and sealed with a septum. 
After taking an initial NMR spectrum, trimethylsilyl iodide (21.8 ul, ). 153 mmol) was 
added, and the solution vortexed and placed in an Abderhalden drying flask heated to 56 C. 
After 22 hrs., the reaction was judged to be complete and the contents of the NMR 
tube was poured into 4 mis ammonium bicarbonate buffer (25 mM). The aqueous solution 
was extracted 3 times with equal volumes of ethyl acetate. The resulting aqueous solution was 
lyophlized. 
The residue was dissolved in 3 ml nanopure water and covered with 3 ml ethyl acetate. 
The aqueous layer was acidified with one drop IM HCl which caused the yellow colored 
product to be extracted into the organic layer. The aqueous layer was extracted with an 
additional 3 ml ethyl acetate and the extracts were then combined, dried with sodium sulfate, 
filtered and ethyl acetate removed under vacuum to give the product in quantitative yield. Rf= 
0.6, 1:1 0.1% TFA CHgCN, C-18. NMR (300 MHz, dg-acetone) Ô = 8.92 (d, IH, J = 
2.5), 8.68 (dd, IH, J = 2.5, 8.7), 8.05-7.86 (m, 6H), 7.63-7.45 (m, 4H), 7.13 (s,lH), 5.70 (t, 
IH, J = 9), 4.52-4.39 (m, IH), 4.08 (q, 2H, J = 7.2), 3.15 (bs, 2H), 1.18 (t, 3H, J = 7.2). 
HPLC: r.t. = 12.5 min. on Alltech C-18 econosphere 4.8 x 250 mm; f r. = 1 ml/min.; 50% 
CH3CN 50% H2O with 0.1% TFA. 
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Conjugation of hapten to protein 
10 mg of 17 were placed in a 2 ml vial and dissolved in 0.5 ml distilled acetonitrile. 
Next, 8.6 mg water soluble carbodiimide and 5.2 mg N-hydroxysuccininide were added and 
the reaction mixture was stirred for 2 hours. The solvent was then removed under vacuum. 1.0 
ml of a 4 mg/ml KLH solution in pH 7.4 PBS was added to a clean and dry 2 dram vial. Next, 
300 ul of a 300 mM pH 8.4 BBS solution was added followed by 103 ul of a 5.6 mg/ml 
solution of the hapten as the NHS ester. 
The final solution, which was 64 mM borate and 8% acetone, turned slightly cloudy 
upon the addition of the acetone solution. 
The solution was vortexed for 3 hours at 4 C. 
To purify the conjugate, a sephadex G-50 size exclusion column (150 mm x 15 mm) 
was used. 1.5 ml fractions were collected using pH 7.4 PBS as eluent. Fraction 3 contained 
the largest protein concentration which was determined by BCA assay to be 1.5 mg/ml. 
The extent of conjugation was determined by either TNBS assay22 of free amines on 
the protein before and after coupling and/or by thiolysis of the dinitrophenyl group of the 
hapten by mercaptoacetic acid. The thiolysis reaction was carried out in pH 7.0 phosphate 
buffer under conditions worked out by D. V. Jewell who was an undergraduate student 
working under my direction. 
Thiolysis procedure 
Sodium phosphate (116.1 mg, 0.814 mmol) was dissolved in 965 ul nanopure water 
and the container then purged with nitrogen. Mercaptoacetic acid (25 ul, 0.467 mmol) was 
then added to the aqueous solution and, after mixing well, the solution was transfered to a 
quartz cuvette. The cuvette was then placed in a thermostated cuvette holder set at 35°C and 
allowed to equilibrate for five minutes. After this period, 10 ul a 9,0 mM solution of the DNP 
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derivative to be analyzed (in nanopure water) was added and spectra were taken every three 
minutes. The reaction was judged to be complete after 18 minutes and the pH at this time was 
found to be 6.6. 
The thiolysis product mixture was extracted into ethyl acetate after acidification of the 
aqueous layer with sulfuric acid and, after drying with sodium sulfate, the solvent was 
removed under vacuum. A standard using /-Boc-(DNP)-histidine was treated in the same 
manner. The residue was dissolved in HPLC eluent to make it 5,5 mg/ml and components 
were then quantified by HPLC using an isocratic eluent of 1:1 acetonitrile : 0.1% TFA/H2O 
and a flow rate of 1.0 ml/minute and monitoring at 340 nm. An Alltech econosphere C-18 
column (length = 250 mm i d. = 4.6 mm) was used for the analysis. Quantitation of the peak 
eluting between 5.0 and 5.4 minutes, which corresponds to the dinitrophenyl mercaptoacetic 
acid, indicated that three to four haptens per protein were present. 
The procedures for conjugation of hapten to protein were the same when using BSA 
or LPH except that the hapten was in DMF solution when conjugated to BSA and the LPH 
conjugate was purified on a sephadex G-25 size exclusion column. 
bis (m-carboxyphenyl) carbonate (18) 
Triphosgene (66.0 mg, 0.2224 mmol) was weighed into a dry flask under nitrogen. 
Benzyl /w-hydroxybenzoate (225.6 mg, 0.9884 mmol) was weighed into a separate flask, 
traces of water were removed by azeotrope with toluene, and a solution of the phenol in 2.0 
ml CH2CI2 was prepared (0.49 M). Three equivalents of the phenol (0.6672 mmol) was added 
to the solid triphosgene followed by 0.16 ml pyridine (1.978 mmol). TLC after 30 min. 
indicated that some of the product carbonate had formed but also showed that unreacted 
phenol was still present. The remainder of the phenol solution was added after observing this. 
After 5 hours, starting phenol was still observed by TLC. To test whether the phenol 
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seen could be from hydrolysis of the chloroformate, the reaction mixture was cospotted with 
ammonia saturated methanol. Phenol was still observed but there was also a new spot at Rf 
0.1. This test was not conclusive. After stirring overnight, 0.200 ml water was added to 
hydrolyze any remaining phosgene and to convert chloroformate to carbonate. Bubbling was 
observed immediately but TLC indicated that phenol was still present. After stirring with 
water for 45 min., solvent was removed on the vacuum pump using a KOH trap after 
checking for phosgene with indicator paper. 
EtOAc was added to the crude residue and was extracted three times with pH 2-3 
0.02M sodium bisulfate. After drying over sodium sulfate, solvent was removed under 
vacuum and proton NMR and IR were taken that the desired bis (m-(benzyloxy-
carbonyOphenyl) carbonate had been formed quite cleanly. The product had an Rf virtually 
identical to that of benzyl w-hydroxybenzoate using EtOAc/Hexanes as eluent however it was 
found that product and starting material could be separated using 40:60 CCl4;CH2Cl2 as 
eluent. The mixture was flashed in this eluent to give 176.2 mg (70% yield) of carbonate. FT-
IR (CDCI3, cm-') 3067, 3034, 2955, 1780, 1719, 1589, 1445. NMR (300 MHz, CDCI3) Ô 
= 5.36 (s, 4 H), 7.24-7.49 (m, 18(14) H) 7.96-8.02 (m, 4 H). 
The (w-(benzyloxycarbonyl)phenyl) carbonate was dissolved in 5 ml EtOAc and the 
benzyl groups were removed by hydrogenolysis using 10% Pd/C (51.1 mg) as catalyst. After 
stirring overnight, starting material was gone and a white solid had precipitated. The mixture 
was filtered through celite and the solid rinsed with 15 ml CH3CN, The solvent from the 
combined rinsings was removed m vacuo to give 80 mg (0.2645 mmol, 72% yield) white 
solid. FT-IR (CH3CN, cm-l) 3336, 3033, 1781, 1564. 'H NMR (300 MHz, CH3CN) 5 = 
7.23-7.51 (m, 5(4) H) 8.01-8.08 (m, 4 H). 
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Immunoassays 
After obtaining antibody-containing hybridoma supernatant samples for Dr. Van 
Deusen's laboratory, they were screened for their ability to bind the hapten used to elicit 
antibodies. This was done using established ELISA procedures23a,b where the hapten is linked 
to BSA which is, in turn, adsorbed to a polystyrene. Antibody which binds the hapten can then 
be detected by addition of goat-anti-mouse antibodies conjugated to horseradish peroxidase 
followed by addition of ABTS. 
Carbonate Coupling 
A solution of 100 mM bis(/»-carboxyphenyl) carbonate was prepared by dissolving the 
solid in pH 8.0 BBS. Next, Njin-DNP-histidine ethyl ester was dissolved in pH 8.0 BBS to 
make a solution which was 300 mM in Ni^-DNP-histidine ethyl ester. The two solutions were 
mixed (0.5ml of each) and either 100 ui PBS or 100 ul of the antibody sample was added. The 
test tubes were vortexed and the the reaction solution sampled at 30, 60, 90, 120 and 240 
minutes. 
100 ul of the reaction solution was diluted with 400 ul water, acidified to pH 2 with 
100 ul 0.1 M NaHSO^, and then extracted with 4 x 1.0 ml ether. The ether extracts were 
dried by passing through a pipet containing Na2S0^ and the solvent was then removed under 
vacuum. The residue was then dissolved in HPLC eluent to make it 2 mg/ml and analyzed by 
HPLC For HPLC analysis, an isocratic eluent of 1:1 acetonitrile : 0.1% TFA/H2O and a flow 
rate of 1.0 ml/minute was used. The amount of w-hydroxybenzoate (retention time 3.0-3.1 
min.) was determined by monitoring at 252 nm. An Alltech econosphere C-18 column (length 
= 250 mm i d. = 4.6 mm) was used for the analysis. 
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PAPER n 
SENSITIVE DETECTION OF CATALYTIC SPECIES 
WITHOUT CHROMOPHORTC SUBSTRATES 
42 
INTRODUCTION 
With the steady progression in the development of catalytic antibodies as useful 
models of enzymic reactions and as synthetic tools, it has become increasingly important to 
streamline the production of the desired antibody. To this end, general rules or factors 
important for the successful generation of catalytic antibodies need to be outlined. This area 
includes factors important in the structure and design of the hapten. Another area that needs 
to be developed further, is the rapid and accurate screening of the potential catalyst pool for 
the desired catalytic activity and specificity. A typical sample from a spleen cell fusion will 
produce hybridoma cells generating as many as 10* different antibody structures.^ From this 
large pool, it is necessary to find the few candidates for catalysis as quickly as possible. In 
addition, many non-antibody producing hybridoma cells are also present and these cells tend 
to multiply more rapidly than those which do produce antibody.'* As a result, hybridoma cells 
producing potential catalysts may be starved out in the cell culture medium unless they are 
identified and isolated in a short period of time. The concentration in hybridoma supernatant is 
typically very low making screening by HPLC analysis of reaction product impractical. An 
assay therefore, is needed which is very sensitive, rapid, and specific for catalysts of the 
desired reaction. It has been observed in more than one case that in screening for antibodies 
that bind the hapten, many good catalysts can be overiooked. These catalysts may provide rate 
accelerations through methods other than simply preferential binding of the transition state 
structure.^®"*' The best approach may involve augmenting "mechanism-based" hapten design 
with direct genetic screens for catalytic activity. The generation of protein and polynucleotide 
structures from combinatorial libraries looks to be a promising general method for the rapid 
production of catalytic species.^"^® In this method an even greater number of structures may 
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be produced. 
To date, most assays that have been used to screen directly for catalytic activity 
involved antibody-catalyzed hydrolysis reactions in which a chromophoric group was 
generated. Although this method was fairly sensitive it could not be used as a general 
assay since it places a limitation on the hapten design as the chromogenic moiety must be 
incorporated. Tn the past couple years, researches have begun to focus more attention on the 
development of a sensitive and general catalytic assay and some notewothy advances have 
been made. 
Recently, Peter Schultz and coworkers have developed a chromogenic assay for 
screening large antibody libraries. * The assay is useful in that it may lend itself to the screening 
of bacterial colonies or {Vaques generated by mutagenesis or combinatorial strategies. 
The assay was developed by using the catalytic antibody 48G7 as a model. '2 This antibody 
catalyzes the hydrolysis of/'-nitrophenyl esters and carbonates. A chromogenic substrate 2 
was designed, which consists of 3-hydroxyindole (4) linked to the />-nitrophenyl carbonate 
moiety via 4-hydroxybutyric acid (Scheme I). It was envisioned that hydrolysis of the 
carbonate top-nitrophenol and indolylbutyric acid (3) should be followed by rapid 
intramolecular cyclization via attack by the generated hydroxyl group to give butyrolactone 
and 3-hydroxyindole. Under the reaction conditions, 3-hydroxyindole undergoes oxidative 
dimerization to form the chromophore indigo, which rapidly precipitates to indicate the 
location where the hydrolysis took place. The indigo, with an extinction coefficient of29,700 
can then be sensitively detected. 
The rate of hydrolysis of substrate 2 was assayed by monitoring nitrophenyl release 
spectrophotometrically and found to be comparable to the hydrolysis of other substrates, such 
as 4-nitrophenyl butyl carbonate 5, which do not contain the hydroxyindole moiety. 
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Scheme I. Generation of indigo chromophore 
Antibody catalyzed hydrolysis of 2 resulted in the formation of 0.3 equivalents of 
indigo per equivalent ofp-nitrophenol. Indigo formation was found to be dependent upon 
antibody catalytic activity. In the absence of antibody, no indigo formation was detected. The 
antibody-dependent indigo formation was inhibited by the nitrophenyl phosphonate transition-
state analog 1 to which the antibody was generated. In addition, the benzyl ether of 
indoylbutyric acid 3 did not form detectable indigo when incubated with the antibody, 
indicating that the formation of indigo is not simply due to the antibody catalyzed hydrolysis 
of the indoyl ester. The fact that the indigo chromophore precipitates from solution enhances 
the sensitivity of this assay as other chromophores such as /?-nitrophenol are diluted by rapid 
diffusion. The assay has also been applied to the detection of an antibody (7D4) which 
catalyzes the hydrolysis of alkylphenyl carbonates, a reaction in which no visible chromophore 
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is produced. In this latter case, the 5-bromo-4-chloro-indolyl substrate 6 was needed. 
In general, the authors have introduced a clever idea for the detection of catalytic 
antibodies. The assay seems to be quite sensitive and directly applicable to the screening of 
bacterial colonies on agar plates and provides a simple qualitative assay of catalytic activity 
rather than hapten binding. The production of an insoluble dye or indicator is essential in order 
to localize the positions in which colonies are producing antibodies of the desired activity and 
specificity. These efforts will undoubtedly bring more attention to the importance of 
developing sensitive screening assays and will lead to more generally applicable assays. 
Although the assay is useful and may be applicable to the screening of catalytic 
antibodies produced in bacterial colonies or plaques, it appears to be limited to the detection 
of esterolytic reactions. High backgound from the non-specific hydrolysis of the labile 
carbonate or ester may be misleading. In addition, it requires that the indolylbutyric acid 
moiety be present at the reacting center which may limit the number of reactions for which 
one can screen. One can envision that in some cases antibodies could directly hydrolyze the 
indolyl ester given the large variety of antibodies produced. Although the authors do not 
mention why the 5-bromo-4-chloro-indolyl substrate 6 was needed when studying the second 
antibody (7D4), it may be to prevent hydrolysis of the indolyl ester by making it less 
accessible. 
In a recent article, Green and coworkers have introduced a catalytic assay based on 
existing ELIS A methodology.^ The idea behind their assay is to have the antibody substrate 
bound to a surface. The surface is then exposed to a solution containing the antibody sample 
and if it is catalytic, it will accelerate the formation of the desired product. Anti-product 
antibodies from rabbit, which were previously prepared, are then bound to locations in which 
product had been produced. Finally, the surface is exposed to an enzyme-labeled second 
antibody which binds the mouse antibody and the enzyme catalyzes the formation of a colored 
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product indicating that the desired product was formed. 
They tested the feasibility of this strategy by studying the enzyme- or base-catalyzed 
hydrolysis of esters 7a-d and imide 11. The BSA conjugates of these substrates were absorbed 
to microtiter plates then treated with either pH 10.9 sodium carbonate solution or pancreatic 
lipase, an enzyme which can catalyze the hydrolysis of esters. Formation of the resulting acid 
product 9 was then determined by conventional ELFSA using the rabbit anti-9 antibodies 
OH Linked to 
RX' 
HjO 
\ 0 
Substrate (7, X = 0; 8, X = NH) 
o o 
Linked to 
-OH no A 
RXH + HO^ ^ ^  ^  ^ 
Product (9) " ° 
followed by peroxidase-linked, anti-rabbit immunoglobulin antibodies. No signal was seen for 
the amide analogs of 7a-d which are not substrates. The rates of hydrolysis of esters 7a-d in 
the presence of various concentrations of lipase reached a maximum at relatively low enzyme 
concentration. They attribute this to the small amount of substrate which is absorbed to the 
microtiter plate. 
The researchers then applied the assay to the screening of antibody supernatant for 
catalysis. To generate catalytic antibodies, they used a phosphonate hapten 10 which 
mimicked the transition-state for the desired hydrolysis reaction. After fusing the immunized 
mice spleen cells with an immortal myeloma cell line, the resulting 1570 hybrid clones were 
Esters fX = 0) 
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assayed for their ability to induce the hydrolysis of ester 7a and amide 8. Of the dozens of 
clones that bound hapten 10, only two were found to give a positive signal in the assay, 
indicating that catalysis had taken place. The catalytic antibodies isolated showed remarkable 
specificity as they were specific for the /»-nitrobenzyl ester 7a while 7b-d were not accepted as 
substrates. 
This assay developed by Green and coworkers is of utility in that it allows for the 
screening of large numbers of hybridoma supernatant samples using existing ELIS A 
methodology which is already very familiar to researchers in this area. The assay also seems to 
be quite specific in screening for antibodies capable of catalyzing the desired reaction. The 
signal observed, however, was not much above that observed for hydrolysis in pH 8.25 TBS 
solution. Again, as in the preceding example, the question of general applicability arises 
although it is not nearly as limited as the former. The system requires the use of a product-
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specific antibody which must be produced through costly and time-consuming immunological 
methods. It may be possible to lower this cost through use of polyclonal antibodies however, 
questions of selectivity still remain. As a result, this could be a limitation if the detection of a 
number of different products is desired. In that case, many new product-specific antibodies are 
required. The reaction screened for, as in the last example, is an ester hydrolysis reaction and 
is somewhat limited in this regard although it is possible that the acid moiety could be used as 
a label for a second substrate in a coupling reaction. If the detailed study of a single reaction is 
desired, this assay has a certain advantage in that it poses no limitation on the substrate or 
product structure (other than the ability of the immune system to recognize it). 
The Green assay could be applied to reactions in which two molecules are coupled 
together. These reactions are of much greater interest fi'om both a synthetic and mechanistic 
point of view and a general assay for the detection of catalysts for this type of reaction would 
be invaluable. The assay, as was the goal of those mentioned above, should be general, 
inexpensive, rapid, and easily applied to the handling of large numbers of samples. In the 
following sections, I will discuss the development of such an assay which does not impose any 
restrictions on the reaction center and is operationally quite similar to the ELISA already 
employed to detect antibody binding to substrate. 
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RESULTS AND DISCUSSION 
In the development of antibody catalysts and other protein catalysts from 
combinatorial libraries it is becoming increasingly important to be able to screen the large 
number of potential catalysts produced. In order to effectively screen the large pool of 
candidates generated from current methods, a very sensitive and preferably simple assay must 
be developed. The ELISA, which is used to detect antibody binding to hapten molecules, is a 
very sensitive assay for detecting dilute amounts of antibody. It is also convenient to perform 
as a simple and general protocol has been developed. It was a logical extension then, to model 
our desired assay for detecting catalysts of bimolecular reactions after this procedure. 
The general idea for our assay was to have one substrate for a catalyst bound to a 
surface which could be manipulated and washed. The second substrate would then be bound 
to a tag which could easily and sensitively be detected. 
As a tag, we chose biotin since it is bound by the protein avidin with a dissociation 
constant of 10"'^ M. When a solution of the labelled substrate and the catalyst is exposed to 
the surface bound substrate, a covalent attachment between the two substrates is formed 
resulting in the tag being irreversibly bound to the surface. Any unreacted labelled substrate 
could be simply rinsed away. Biotin on the surface could then be detected using an enzyme 
amplification procedure involving streptavidin linked to the enzyme horseradish peroxidase. 
Exposing the modified surface to a solution of this protein conjugate results in the horseradish 
peroxidase (HRP) being bound at those sites where a reaction has taken place. As the final 
detect 
A + 
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step in this sequence, the surface is rinsed free of unbound HRP and then exposed to a 
chromogenic substrate for the peroxidase such as 3-ethyl-2-azino-benzthiazoline sulfonate 
(ABTS). As a result, a colored spot is observed at those locations on the surface where a 
reaction has taken place. 
For practical purposes, it becomes apparent that the assay's success depends on the 
fidelity of all the steps along the way to the final color development. Specifically, it requires 
that all of the rinsings completly remove unbound reagents and that the reagents used to 
visualize the biotin tag are all functioning at maximum sensitivity. An additional consideration 
in this assay is that the detection of a bimolecular reaction is desired and one of the substrates 
by definition must be essentially stationary. Thus, the rate is going to be affected by how 
rapidly the soluble substrate and catalyst can diffuse to the surface. Also, since a bulky protein 
catalyst is being studied, it becomes all the more important that the substrate is easily 
accessible so that steric hindrance between the surface and the catalyst is not a problem. For 
this reason, a long, flexible linker is needed to force the surface bound substrate into the bulk 
solution. 
The advantages of this assay procedure lie in its sensitivity and in its generality. By use 
of the commercially available streptavidin-horseradish peroxidase and ABTS developing 
system, a very sensitive signal can be generated. This is a result of the amplification that takes 
place as the peroxidase enzyme converts many ABTS substrate molecules to their 
corresponding intensely colored oxidation product. Fn most cases, the results can be observed 
visually as a green color and can be measured quantitatively with the use of a 
spectrophotometer. ABTS is a convenient substrate as it is commercially available and forms a 
distinct water soluble dye. However, other visuallization sources such as chemiluminescent 
substrates are also available and in some cases may provide even greater sensitivity. The assay 
has generality in that there are no chemical requirements at the reacting center. No 
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chromophoric substrate need be produced by the reaction assayed. The substrate molecules 
must be tethered to either a surface or to a biotin tag however, as the position of these tethers 
is not important, much greater flexibility is achieved. As was already mentioned, existing 
catalytic assays have been used to detect hydrolysis reactions generating a chromophoric 
leaving group. Although this type of assay has been used with success, it is confined to the 
study of hydrolyses involving chromogenic substrates. Another disadvantage is that sensitivity 
may be lost due to background hydrolysis of the active ester. Until now, no assay has 
adequately addressed the problem of screening for catalysts of bimolecular coupling reactions. 
The development of catalyst of this type is likely to be important in a number of synthetic 
applications. As one further advantage, we envisioned that since the assay is operationally 
quite similar to the ELISA, it should be possible to perform screening of various catalyst 
samples in parallel. 
Assay Development 
To develop a working assay, we chose to study the reaction involving solvent 
damaged ct-chymotrypsin catalyzed aminolysis of amino acid esters. Wong has previously 
reported that the serine protease a-chymotrypsin can act to catalyze irreversible amide bond 
formation in aqueous media containing greater than 55% organic cosolvent'^. The most 
suitable substrates are the methyl esters of hydrophobic amino acids as acyl donor and alanine 
or other relatively unhindered amino acids as acyl acceptor. 
Chymotfypsin 
CHjCNiHjO 
e0;40 
H O 
H O ' H 
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Under the reaction conditions, chymotrypsin is a useful, although not particularly 
stable catalyst for this transformation. For this reason we considered it to be a relevant 
benchmark to gauge our assay for its potential to detect protein catalysts, which initially may 
be only moderately efficient catalysts. Therefore, to determine the sensitivity of our assay, we 
studied the chymotrypsin-catalyzed coupling of an N-acylated tyrosine methyl ester with an 
alanine amide in 60:40 acetonitrile:water. 
The first step in the assay development was to synthesize the desired modified amino 
acid substrates. Since the aminolysis reaction requires high concentrations of the acyl 
acceptor, it was necessaiy to have alanine as our soluble substrate so that the concentration 
could be easily controlled. 
OH 
H 0 o 
o 
o 
Attach 
to 
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Attat 
to 
ta£ 
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Therefore, alanine would have the biotin tag. Initially, an aminocaproyi ethylene 
diamine linker was used as a spacer between alanine and the biotin tag to form 15. The p-
methylsulfinylphenyl ester of aminocaproic acid, which had been previously prepared, was 
aminolyzed by treatment with ethylene diamine. Acylation of the free amine 14 with biotin 
NHS ester followed by removal of the /-butyloxycarbonyl protecting group afforded the 
desired reagent. Initial experiments were performed using this substrate, however it exhibited 
poor solubility in the solvent mixture used for the assay and it soon became obvious that a 
more soluble derivative would be required. 
•SPh H2NCH2CH2NH2 
2) HCl 
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For this reason, I turned to the use of the much more soluble tetraethylene glycol 
derived linkers reported by Bednarski and coworkers. Along the way, I have developed new 
procedures for the preparation of linkers complimentary to those of Bednarskiand I will 
discuss this further in the next section. The synthetic sequence leading to the desired substrate 
is shown. This synthesis began again with the preparation of the active /-Boc alanine N-
hydroxysuccinimide ester 16 as described in the literature^^. /-Boc-aJanine NHS ester 
was then used to acylate the amino azide 17 using pyridine and methylene chloride as solvent. 
The amino azide, obtained from extraction, contained triphenylphosphine oxide as a 
byproduct. However, the ratio of triphenylphosphine oxide to amino azide could be calculated 
by NMR integration and the acylation product could be purified through silica gel 
chromatography to give pure 18 in 68% yield. 
o 
CH2CI2 
o 
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The azide function was converted to the corresponding amine through reduction with 
triphenylphosphine and was subsequently acylated by biotin NHS ester. The protected form 
of the substrate could then be purified through flash chromatography and stored in this form. 
Removal of the /-Boc group by HCl saturated THF affords the desired substrate as the 
hydrochloride salt of 13. 
19 
Biotin NHS ester 20b was prepared by the literature procedure*^ which involved 
drying both biotin and N-hydroxysuccinimide overnight over P2O5 in vacuo. Biotin was then 
reacted with carbonyldiimidazole at 80°C in DMF and the intermediate biotmylimidazolide 
20a, which precipitated from solution, was then treated with NHS to form the product. The 
crude product could be recrystallized from refluxing isopropanol to give the pure product in 
78% yield. 
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The acyl donor, which was chosen as tyrosine methyl ester based on the observations 
by Wong was modified for coupling to a support by reaction with glutaric anhydride. The 
resulting hemiglutaryl tyrosine methyl ester 21 could then be activated through various means 
such as formation of the NHS ester 22, and then coupled to a support containing a 
nucleophile. 
4 
NHS, DCC 
• 
CH3CN 
DMF 
80° C 
CIH3N, 
EtaN HO, 
^ 
CH2CI2 
OH 21 
OH 
22 
OH 
57 
Our first choice of a support for the acyl donor was the protein bovine serum albumin 
(BSA) adsorbed to polystyrene. (Interestingly another support, polyallyl amine was also tried 
in early experiments but the results showed that the support itself caused the conversion of 
ABTS to its green oxidation product. This could possibly be due to the presence of metals 
present m the polymer sample.) This is the standard protein that we and many other 
researchers have used as the support for hapten conjugates in ELISA screenings. The 
substrate molecule can be covalently linked through amide bonds to the lysine side chains in 
the protein. 
A quantitative determination of the number of free amino groups before and after 
coupling indicates the number of substrates bound per protein. The protein can then be 
irreversibly adsorbed to the wells of a polystyrene microtiter plate and, after blocking any 
remaining polystyrene surface by exposure to more BSA, the well is exposed to a solution of 
catalyst and acyl acceptor. After the reaction has taken place, the biotin label is covalently 
bound to protein and is thus fixed to the surface, with the weakest connection being that of 
the interaction of protein with the polystyrene surface. It then becomes necessary to rinse 
away excess reagents without rinsing off the absorbed protein. Tween 20, a non-ionic 
surfactant is a good choice for this purpose as it does not denature proteins. After these 
rinsings, the biotin label is then detected using the standard streptavidin-HRP / ABTS 
detection system*^ and absorbances are read at 415nm. 
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To test the feasibility and detection limits of this approach, a model experiment was 
run in which BSA absorbed to the wells of a microtiter plate, was exposed to a buffered 
solution of biotin and varying amounts of N-ethyl-N'-dimethylaminopropyl carbodiimide 
hydrochloride (WSC), a reagent known to couple carboxylic acids to amino groups in 
proteins. Under the conditions assayed, it was found that coupling could be clearly detected 
down to WSC concentrations of 15 uM at pH 6.2 and 30 uM at pH 7.4, This indicated that a 
moderately good catalyst could be detected at low levels and that the strategy was worth 
pursuing. 
HO" 
BSA—NHz 
BBS BSA-NH' 
When the coupling assay was initially tried under the described conditions, what was 
observed was that both chymotrypsin and biotin-labelled alanine were required to give the 
strongest signal. Various controls were performed, however, which indicated that just 
chymotrypsin alone gave a signal half as strong as that when biotin-labelled alanine was also 
present. This result was difficult to explain but could be due to the chymotrypsin causing some 
of the polystyrene surface to be exposed so that in the subsequent incubation with 
streptavidin-HRP, some may have been non-specifically absorbed to the surface giving rise to 
the signal. It did seem that a portion of the signal (approximately half) could be attributed to 
the coupling reaction. To increase the accessibility of the tyrosine methyl ester, a linker, I-
methylcarboxy-1,3,6,9-tetraoxa-1 l-azidoundecane, was inserted between the BSA and the 
substrate through WSC-mediated coupling followed by reduction of the azido function with 
tris(carboxyethyl) phosphonium hydrochloride. The linker however, did not appear to make a 
difference when compared side by side with the substrate not containing the linker, A 
subsequent experiment in which chymotrypsin concentration was serially diluted showed an 
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approximate dependence of observed signal on chymotrypsin concentration. In this 
experiment the background signal with chymotrypsin alone was not observed. Up to this point 
however, no experiment was run in which the acyl donor, tyrosine methyl ester, was absent. 
The next experiment addressed this question. In addition to absorbing BSA-tyrosine 
methyl ester to the surface, a row of wells, to which unmodified BSA had been absorbed, was 
used as a control. Both the modified and unmodified BSA were exposed to a solution of acyl 
acceptor, chymotrypsin, or both. From this experiment, it was found that although the 
controls in which chymotrypsin or biotin-labelled alanine had been omitted were negative, an 
equally strong signal was observed for both the reactions with and without tyrosine methyl 
ester. Therefore, both chymotrypsin and biotin-labelled alanine are required for a positive 
result but tyrosine methyl ester is not. One possible explanation for this is that the 
chymotrypsin retains some of its amidase activity forming acyl enzyme with the BSA, which is 
then aminolyzed by biotin-labelled alanine. Decreasing the reaction time, which had been 
several hours, to several minutes may help as the ester should react more rapidly than the 
amide. Also, up until this point a one to one mixture of acetonitrile and water had been used. 
Using a higher percentage of organic cosolvent would help in that case. The problem with 
using too high a concentration of organic solvent is that this decreases the solubility and 
stability of the enzyme. 
It would be nice to know what component of the signal was due to reaction with 
tyrosine methyl ester, that is, is there any enhancement of signal due to the recognition and 
greater reactivity of tyrosine methyl ester substrate with chymotrypsin. In order to have a 
chance at seeing this effect, besides making the changes described in the preceeding 
paragraph, it is also necessary to lower the concentration of catalyst to see better selectivity. 
This would also give limits of detection for the assay. To this end, rows containing BSA-
TyrOMe and BSA were absorbed to the surface, then a solution of biotin-labelled alanine and 
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varying amounts of chymotrypsin in 60:40 acetonitrile:water were placed into the wells. After 
developing, it was found that chymotrypsin could clearly be detected down to 0.1 uM in the 
presence of BSA containing tyrosine methyl ester and to 1 uM when BSA without tyrosine 
methyl ester was present. At a fixed chymotrypsin concentration of 6 uM, biotin-labelled 
alanine down to 3.6 mM could be detected. These results, shown in Figure 1, indicate an 
approximately ten fold difference in sensitivity attributable to the presence of the substrate 
acyl donor on the surface. 
It was decide that it would be necessary to eliminate the signal from the presumed 
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Figure 1. Absorbance at 415 nm vs. concentration of chymotrypsin catalyst with 
(upper curve) and without (lower curve) tyrosine methyl ester. 
background reaction of chymotrypsin with BSA. For this reason, the feasibility of using other 
supports was studied. The use of nitrocellulose as a solid support for ELISA had been 
reported previously^ so this was looked at first. As an initial test, biotin was coupled to 
nitrocellulose via biotin NHS ester and this was then exposed to the reaction conditions. It 
was found however, that the nitrocellulose paper was not compatible with the 60% 
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acetonitrile cosolvent used in the assay. For this reason, the use of chromatography paper as a 
solid support was then examined. 
Lebl and coworkers had reported the use of Whatman chromatography paper as a 
solid support for peptide synthesis^^ so it seemed reasonable that it could also be used for the 
purposes of our assay. To this end, surface hydroxyl groups on the paper were acylated with 
azido acid 23 as outlined in the scheme below. The azido group was then reduced to the 
amine using stannous chloride and finally, the free amine was acylated with the NHS ester of 
hemiglutaryl tyrosine methyl ester. Between coupling steps, the paper was extensivly rinsed 
with a variety of solvents. Coupling was confirmed by reflectance IR and by quantitative 
ninhydrin assay. It was also found that it was important to wash the paper with aqueous base 
after the reduction in order for successful coupling in the next step. 
o 
CeKuiose—% • Cellulose— 
DCC, HOBt, DMAP 
24 
o I) SnClz, MeOH o o 
CelUose— • Cellulose— 
When this new sample of acyl donor was tested in the assay, successful results were 
obtained. The paper sample was cut into a small disk and placed in the bottom of a microtiter 
plate well. It was then exposed to a 60% acetonitrile solution containing biotin-labeled alanine 
and chymotrypsin for two minutes as described above. Controls were also run in which one or 
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more of the required elements was omitted. After developing, it was found that the two wells 
containing the catalyst and the two substrates gave a signal much stronger than the others. 
Paper without ester substrate is ineffective, and biotin tethered to /-Boc-alanine, without the 
nucleophilic amine, also leads to no signal above background. Background, in this case, was 
the signal obtained ft-om incubating underivatized paper with only chymotrypsin 
Once the desired response was obtained, the next step was to find the optimal 
conditions and limitations for the assay. On varying conditions, it was found that pre-blocking 
the paper with a solution of Tween 20 was important to decrease the amount of background 
signal. Optimal amounts of hydrogen peroxide and ABTS in the developer were also 
determined as well as the appropriate dilution for the streptavidin-HRP conjugate. By varying 
the volume of reaction solution, it was found that as little as S ul of solution could be used 
with a clear signal still obtained. Next, the effect of reaction time was examined by allowing 
the reaction to go for twenty or two minutes. Wong's studies indicated that longer reaction 
times could result in some cleavage of peptides formed. The results of this experiment, as 
shown in Figure 2, indicated that a reaction time of twenty minutes gave a better signal as 
illustrated by the upper line in the figure. Controls in which a chymotrypsin catalyst was boiled 
to eliminate activity gave much lower signal. Various cosolvents were also screened for their 
efficacy in coupling and we have found several that appear to be equivalent to the acetonitrile 
system identified by Wong et al^^. Although duplicate experiments reveal a fairly large scatter 
in some cases, it does provide a good illustration of the potential application of the assay. 
A titration of chymotrypsin concentration was also performed in order to find the 
sensitivity limits of our assay. Chymotrypsin concentrations were varied from 38 to 0.25 nM 
and it was found that a clearly visible signal was detectable down to 1 nM. Considering that 5 
ul of solution were used, this corresponds to the detection of only 5 femptomoles of catalyst. 
The absorbance increases linearly with increasing chymotrypsin concentration in the range 
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Figure 2. Absorbance at 415 nm vs. chymotrypsin concentration (nM) at reaction 
times of 2 (lower curve) and 20 (upper curve) minutes. 
between 0 and 10 nM however, at higher concentrations, absorbance was observed to level 
off. This leveling off of absorbance occurred concomitantly with the development of a purple 
color on the paper which could be an oxidation byproduct from the enzyme reaction. The 
results are illustrated in Figure 3. 
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Figure 3. Absorbance at 415 nm vs. chymotrypsin concentration (duplicate runs). 
Reaction time = 20 minutes. 
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An attempt was also made to link hemiglutaryl tyrosine methyl ester to paper through 
a tetraethylene glycol diamine linker. The linker itself can be covalently attached to the paper 
through a urethane linkage providing a more stable bond to paper. This modification also had 
an advantage in that it would require fewer chemical steps to attach substrate to paper. After 
rinsing with TFA and triethylamine as described in the experimental section, the paper could 
be activated by treatment with carbonyl diimidazole to form 30. Treatment of this intermediate 
with commercially available tetraethylene glycol diamine resulted in the desired amine tethered 
to paper 31 as confirmed by reflectance IR and quantitative ninhydrin assay. Hemiglutaryl 
tyrosine methyl ester could then be attached as described above. Unfortunately, when this 
sample was used in the assay, no signal was observed. It was noted that this linker was slightly 
shorter than the azido acid 23 used previously and this may be the reason for loss of signal in 
the assay. If this is the case, the problem can be overcome by subsequent acylation of the 
amine 31 with azido acid 23 followed by reduction of the azide and coupling of hemiglutaryl 
tyrosine methyl ester. 
o 
Cellulose—OH > Cellulose— 
o 
Cellulose —o— 
31 
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Preparation of useful tetraethylene glycol derived linkers 
In many biological assays it is necessary to couple relatively small molecules to 
proteins or other polymers for purposes of labeling of the protein or immobilization of the 
molecule. In doing so, it is often desirable to use a linker, or spacer arm, between the two 
substituents so that the small molecule is more accessible. Linkers have been widely used to 
attach a variety of small sized tags or labels to a larger polymer such as a protein. Such linkers 
have found use in medicine, as in radiolabeling of organ targeting drugs as well as in the study 
of biological pathways and metabolism of particular compounds. It is essential that the linkers 
used do not interfere with the property being studied and therefore should usually be long, 
flexible and readily soluble in a variety of solvents. The reagent should also contain terminal 
functional groups which can easily react to form covalent linkages with the two molecules of 
interest. Based on the observation of Bednarski et. al. that tetraethylene glycol derivatives 
displayed these desirable properties as linkers, we looked into this application in more detail 
which led to the development of useful new linkers, and improved preparation of known 
linkers for the labeling of a variety of compounds. 
As mentioned above, Bednarski had prepared and used the azido alcohol TEG 
derivative 27 as a linker^*. However, the side products from the reaction, namely the starting 
TEG 26 and the diazido TEG 28 were discarded. Although the starting material is inexpensive 
it would still be desirable to make more efficient use of it as well as the diazide. 
In the linkers which were developed as part of this thesis, both the azido alcohol 27 
and diazide 28 TEG derivatives are used as precursors. The azido alcohol leads to a useful 
azido acid derivative in one step while the diazide can be converted in one step and in good 
yield to the complimentary amino azide linker reported previously by Bednarski in three steps 
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from azido alcohol. The two starting materials, as described by Bednarski, can be efficiently 
separated from one another by flash chromatography. 
The obtained azido alcohol can be converted to the acid azide 23 by alkylation with 
chloro or bromoacetic acid in the presence of potassium hydroxide. A number of reactions 
conditions have been examined in order to find the appropriate conditions to drive this 
reaction to completion. Initially, chloroacetic acid was employed as the alkylating agent, KOH 
as the base, and DMF was used in a minimal amount as solvent in order to stir the reaction 
mixture. While reasonable yields were obtained, the reaction did not go to completion after 
five days even under reduced pressure (to remove water, driving the deprotonation of 
alcohol). It was found that running the reaction between 45 - 55° C helped to accelerate the 
reaction while heating at higher temperatures tended to lead to decomposition of the azide. 
Since using chloroacetic acid as alkylating agent necessarily requires the production of one 
mole of water, the potassium salt was formed prior to the alkylation reaction and this caused 
the reaction to proceed essentially to completion after four days. By further changing the 
alkylating agent to the more reactive potassium bromoacetate, the reaction time was lessened 
to two days at 45° C. 
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It was also postulated that if a stronger base was used, the reaction may be accelerated 
further. Sodium hydride is often used as base in the alkylation of alcohols however, in this 
case the reagent would be a bad choice as it could act to reduce the azido group present in the 
molecule'^. Potassium /-butoxide seemed to be a good alternative as it is more basic than 
hydroxide and is also hindered so that it is not likely to cause the formation of side product by 
displacement. This latter qualification was important since it was desired to purify the acid 
azide by extraction so that the process could be easily scaled up. The consumption of azido 
alcohol was essentially complete within one day, however, although /-butoxyacetic acid did 
not appear to form as a side product, proton NMR of the product after workup indicated the 
presence of other impurities, and the use of f-butoxide was abandoned. 
Since a large excess of both potassium hydroxide and bromoacetate was required to 
ensure that the reaction went to completion in a reasonable amount of time, it was necessary 
to separate the product acid azide from these reagents. Potassium hydroxide can be readily 
extracted into the aqueous phase but bromoacetic acid was observed to be a potential 
contaminant. However, the hydrolysis product of bromoacetic acid, glycolic acid, is quite 
soluble in water and it was found that by adding water and stirring for an additional eight 
hours the remaining bromoacetic acid could be converted to the water soluble glycolic acid. 
One nice aspect of this reaction is that if the starting azido alcohol is pure, any unreacted 
azido alcohol can be recovered in high purity through extraction of the basic aqueous phase 
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with methylene chloride. The desired pure azido acid, as determined by proton NMR and 
TLC, can be made from tetraethylene glycol without the need for chromatography. 
The azido acid thus obtained can be thought of as an N-protected amino acid 
derivative. Once the acid function has been coupled to a desired compound, the amino group 
can be introduced through mild reduction with triphenylphosphine20-22 or stannous 
chloride23-24^ or by catalytic hydrogenation25-27^ thiol reduction28-29 or NaBH^ 
reduction. The amine can then participate as a nucleophile to form a covalent attachment to a 
second substrate or, if desired, form an interaction through ion-pairing. Another desirable 
feature of the techniques developed here is that through the same chemistry, a number of 
linkers may be easily formed with varying chain lengths simply by choosing the starting 
polyethylene glycol of the desired formula weight. 
The second useful linker, the amino azide TEG derivative 17, can be obtained from the 
symmetrical diazide through preferential reduction of only one azido group. Initially, this was 
attempted through palladium catalyzed hydrogénation in the presence of cation exchange 
resin. The idea here was to allow the reduction to take place on one of the azido groups at 
the palladium surface to form the amino azide which would then diffuse away into the bulk 
solution under rapid stirring. When the free amine of the amino azide encountered the cation 
exchange resin, it would be protonated and bound inside by ion-pairing and, as a result, 
protected from the palladium catalyst so that a second reduction could not take place. Once 
all of the starting diazide had been consumed, the resin could be rinsed first with methanol 
followed by ammonia saturated methanol to elute the product. Removal of solvent would then 
afford the desired desymmetrized amino azide as the major product. Methanol was found to 
be the best solvent for allowing the rapid adsorption of amine into the resin. 
Unfortunately, under the conditions described above, decomposition of the starting 
material or one of the formed intermediates was observed. By thin layer chromatography, 
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three separate ninhydrin positive spots were observed. A weaker, carboxylic acid based cation 
exchange resin was also tried however similar results were observed. An explanation for the 
observed decomposition concerns the acidity inside the resin. Once the amino azide had been 
bound to the cation exchange resin, the remaining azido group was exposed to a highly acidic 
environment due to the large concentration of acid in a relatively non-polar medium. 
Decomposition under such conditions could occur through protonation of nitrogen in the 
azide leading to denitrogenation to form and intermediate imine, Hydrolysis of the imine 
would then lead to formation of the TEG derived aldehyde and ammonia. This mechanism is 
outlined in the scheme below. 
T 7 • 
-, B. R—C—N—N-iiNi 
-N2, H+ 
< 
NH, + 
Because of the problem cited above, an alternative route to the selective reduction was 
examined. It was well known that triphenylphosphine is capable of effecting the mild reduction 
of alkyi azides. Since the diazide is readily extracted from aqueous solution into ethyl acetate, 
and triphenylphosphine is clearly more soluble in organic solvents than in water, it followed 
that a selective reduction may be achieved by use of a biphasic organic/water system. 
The idea here is described as follows. The diazide and the reducing agent are dissolved 
in a water immiscible organic solvent over an acidic aqueous solution. Under rapid stirring, as 
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one azide group is reduced to the amine, the amino azide formed (or possibly the intermediate 
phosponimine) will be rapidly protonated and extracted into the aqueous layer, Since the 
triphenylphosphine reducing agent is confined to the organic phase, reduction of the second 
azide will not take place. Instead, diazide remaining in the organic phase will continue to be 
reduced to the amino azide leading to preferential formation of the latter. 
organic 
soluble 
N3 N3 ^ >3 
3 0.25MH3PO4 r 
organic soluble 
17. H+ 
H2O soluble 
Initial conditions studied involved the use of ethyl acetate as organic phase and 0.1 M 
sodium bisulfate as the aqueous phase. Tributylphosphine was chosen initially, however, it 
was found that the partition coefficient of triphenylphosphine for the organic phase was better 
than that of tributylphosine. Besides this, tributylphosphine oxide was seen to remain in the 
aqueous phase to a large extent and it was hoped that the triphenylphosphine oxide formed 
would be more organic soluble. As will be described however, triphenylphosphine oxide has a 
remarkable tendency to associate with a number of hydrogen bond donors. 
Best conditions for the selective reduction were obtained using ethyl ether as the 
organic phase and 0.25 M H3PO4 as the aqueous phase. For the large scale preparation, a 
solution of the triphenylphosphine in ether was added to a stirring mixture of the diazide to 
ensure mixing of the reducing agent prior to reaction. The reaction was found to be complete, 
using 0.85 equivalents triphenylphosphine, after ten to twelve hours. The workup involved 
ether extraction of the acidic solution to remove remaining diazide and triphenylphosphine 
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oxide, followed by addition of sodium hydroxide to make the aqueous solution 4M in 
hydroxide. Subsequent extractions using methylene chloride afforded the amino azide along 
with, surprisingly, triphenylphosphine oxide in a ratio of approximately ten to one. Evidently, 
the high polarity of the phosphorus-oxygen double bond allows the byproduct to remain 
soluble in water despite the three phenyl groups. Some association of the phosphine oxide 
with protonated amine may also be responsible. 
The ratio of amino azide to diamine was determined by HPLC analysis of the CBZ-
protected product mixture, Prior to extraction, the basic aqueous layer containing amine was 
treated with benzyl chloroformate until no amine could be visualized using ninhydrin indicator. 
The product mixture was then extracted into methylene chloride and analyzed by HPLC to 
determine the yield of each product. The results indicated that the amino azide was formed 
preferentially in a ratio of greater than fifty to one. TLC analysis of the amine obtained after 
extraction was consistent with this observation as only one spot corresponding to amino azide 
could be seen using ninhydrin indicator. 
By following the methods developed above, it was possible to carry out the synthesis 
of these useful linkers on a large scale. Thus, 50 g of tetraethylene glycol were treated with 
1.6 equivalents of mesyl chloride followed by sodium azide under the conditions outlined by 
Bednarski to obtain 49 g (85% yield) of a 70:30 mixture of diazide and azido alcohol. 
Alkylation of this mixture with potassium bromoacetate afforded the azido acid in 90% yield 
after extraction. The recovered diazide was purified by flash chromatography and converted 
to the amino azide in 79% yield after extraction. 
It has been demonstrated that the versatile TEG derived azido acid and amino azide 
linkers can be prepared easily on a large scale. Bednarski has demonstrated the utility of TEG 
derived linkers for labeling and conjugation and these linkers have proved vahiable in my own 
72 
work involving the fixation to surfaces or labeling of substrates. It is my hope that 
procedures will be of use to others desiring linkers to serve similar functions. 
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CONCLUSIONS 
An assay has been developed which can be of great general utility in the production of 
novel enzyme and antibody catalysts for bimolecular reactions. The usefulness of this assay 
has been illustrated by using solvent-damaged chymotrypsin as a good model for the types of 
catalytic species which one would expect to find in the initial stages of catalyst production. 
The assay has the following advantages over existing assays: 
- A chromophoric group need not be produced by the reaction 
Requiring the use of a chromogenic substrate puts serious limitations on the 
number and type of reactions which may be studied. 
- Active esters are not used 
The assay detects coupling of substrates not generation of a chromophore in 
the reaction step. In this way, one would not be misled by hydrolysis of the 
actve ester. 
- Many assays may be carried out in parallel 
As the assay is carried out in a 96 well microtiter plate, many reactions may 
be conveniently performed at once. 
- The assay has general applicability 
The only requirement is that one substrate be attached to a surface and the 
other to a biotin tag. 
The assay can be of great utility in the developement of catalytic antibody technology 
where rapid and efficient screening for potential catalysts is essential. With increasing 
advances in the area of combinatorial antibody libraries, which produce even larger repertoires 
of structures, the need for such a screening assay is increased still more. 
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Besides screening to find new catalysts, the assay will also be of great utility in the 
evaluation and study of existing catalysts. The assay, which is rapid, sensitive and easily 
performed in parallel could be used to study structure-reactivity relationships for these 
catalysts leading to a better understanding of the catalyst mechanism. In this way, optimal 
reaction conditions for a particular catalyst would be more easily determined. Currently, 
efforts are under way to apply the assay to the screening of antibodies which could be 
catalysts for a Diels-Alder reaction. Future work could involve minaturization of the assay to 
allow screening of catalysts with varying specificity on a single sheet of paper and the use of 
more sensitive detection methods such as chemiluminescence 
Also, as a spin off of the assay development, methods have been worked out for the 
production of new biflinctional linkers. These linkers afford the desirable properties of 
increased solubility and accessibility in substrates or reagents to which they are attached and 
can be of great use in the labeling or conjugation of a variety of small molecules and proteins. 
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EXPERIMENTAL 
BSA / Hemiglutaryi Tyrosine Methyl Ester Conjugate. 
The NHS ester (22) of hemiglutaryi tyrosine methyl ester (21) (12.8 mg, 
0,0312 mmol) was dissolved in 200 ul DMF. The resulting solution was added to 2.5 
ml of a solution consisting of 10 mg/ml BSA in pH 8.4 borate buffered saline solution. 
Upon addition of the DMF solution to the aqueous protein solution, a small amount of 
white solid, presumably denatured protein, was observed to precipitate from solution. 
The mixture was vortexed at room temperature for 4 hours. The supernatant was then 
taken and the protein conjugate purified on a sephadex 025 size exclusion column. 
TNBS assay indicated that there were 8-10 hemiglutaryi tyrosine methyl esters per 
BSA. 
Cellulose Conjugated to Acid-Azide (24). 
The method of Lebl and coworkers'^ was used for coupling to cellulose. A 5 
cm2 piece of Whatman #1 Chromatography paper was placed in a petri dish and 
soaked in 4 ml 25% TFA/CH2CI2 (30 min.), 3x4 ml CH2CI2 (5 min ), 2 x 5 ml 10% 
Et3N/CH2Cl2 (30 min ), and 2 x 3 ml CH2CI2 The carrier was then pressed between 
filter paper to dry. 
The paper was then treated with 4 ml of 0.1 M azido acid (23)/ DCC / HOBt / 
0,03 M DMAP in DMF. The mixture was allowed to vortex overnight afler which 
time a white precipitate (DCU) had formed. The solution above the paper was pipeted 
off and the paper was then rinsed with 2 x 4.5 ml DMF, 4 x 4.5 ml EtOH (dissolved 
DCU), and 3 x 4.5 mis CH2CI2. The paper was then dried between filter paper. 
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Reflectance IR showed the presence of an azide band at 2111 cm"' and a CO 
band at 1750 cm"' indicative of an ester linkage. 
Cellulose Conjugated to TyrOMe Through TEG Linker (25). 
The azido-acid derivatized paper (24) prepared as described above was placed 
in a petri dish and 5 ml of a 1.3 mmol/ml SnCl] suspension in MeOH was added. The 
dish was vortexed for 2 hours. The paper was then rinsed with 5 x 4.5 ml MeOH, 3 x 
4.5 ml 25% sat'd NaHCO^, 4 x 4,5 ml EtOH, and 3 x 4.5 ml CH2CI2, then dried 
between filter paper. 
Reflectance IR of the paper showed a CO stretching band at 1749 cm'' 
however, no band at 2100 cm"', indicative of azide, was observed. Quantitative 
ninhydrin assay^^ indicated that 60-62 nmol amine were present per each 4.8 mm 
diameter paper disk assayed. 
Esterified cellulose with the free amine was prepared as described above. A 40 
mM solution of hemiglutaryl TyrOMe NHS ester (22) in DMF (3 ml) was added to the 
paper, followed by 1 drop of distilled triethylamine and the paper vortexed overnight. 
The DMF solution was pipeted off and the paper was rinsed with 3 x 4.5 ml EtOH and 
3 X 4.5 ml CH2CI2. 
After drying, a reflectance IR was taken which showed bands at 1742 (ester), 
1660 and 1560 cm"'(amide). Coupling was judged to be complete by ninhydrin assay. 
Paper Linked to Tetraethylene Glycol Diamine (31). 
A procedure analogous to that of Bethell and coworkers was followed.^-^ Whatman 
chromatography paper, which had been washed as described in the preceding procedure was 
dried under vacuum overnight using KOH as desiccant. Next, a solution of 341.1 mg (2.1036 
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mmol) CDI in 6,5 mis acetonitrile (freshly distilled from P2O5) was added to 0.3554 g of the 
cellulose sample (one 5 x 5 cm sheet each of paper and dialysis tubing) contained in a petri 
dish. The dish was placed in a desiccator, which was flushed with nitrogen, and agitated 
occasionally for 45 min.. The acetonitrile solution was then removed and the paper washed 
with 4 X 5 mis freshly distilled acetonitrile. 
After the rinsings, 10 ml of an aqueous solution containing 5 ml tetraethylene glycol 
diamine (Texaco) was added to the petri dish containing cellulose. The dish was then vortexed 
for 16 hrs.. 
After this time, the solution was pipeted off and the paper was rinsed with 4 x 10 mis 
water, 4 x 10 mis IM NaCl and again with 4 x 10 mis water. After 3 x 10 mis rinses with 
EtOFi the paper was dried under vacuum. 
As a control, a clean paper sample* which had not been treated with CDI, was allowed 
to sit overnight under the an identical tetraethylene glycol diamine solution and rinsed in an 
identical manner. Using the control as a blank, reflectance IR was consistent with the presence 
of a urethane functional group (1716 and 1533 cm"*). Quantitative ninhydrin assay indicated 
that 52 nmol amine/mm^ paper was present. 
Hemiglutai^I-L-tyrosine methyl ester (21) 
L-Tyrosine methyl ester hydrochloride (153 mg, 0.714 mmol) from Aldrich was 
suspended in 2.5 ml methylene chloride. The suspension turned to a clear liquid immediately 
after distilled triethylamine (141.7 mg, 1,4 mmol) was added. After the addition of a solution 
of glutaric anhydride (62.3 mg, 0.55 mmol) in 1.0 ml methylene chloride, the reaction mixture 
was stirred at room temperature overnight. The mixture was diluted with EtOAc, and then 
acidified with saturated NaHSO^ to pH 2. Upon dilution with 1.0 ml water, the aqueous layer 
was removed and the organic layer washed once more with 0.1 M NaHSO^ and once with 
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saturated NaCl. The EtOAc was dried over anhydrous sodium sulfate, filtered, and solvent 
was removed under vacuum to give a white solid mixture of 30:1 molar ratio of product to 
glutaric acid as determined by NMR. The adjusted yield was 61%, The NMR spectrum was 
consistent with the desired product except for the glutaric acid contaminant. The crude 
product was used directly for the preparation of the NHS ester. However, an analytical sample 
was obtained by flash chromatography. Rf = 0.35 (85:10:5 CHCI3/CH3OH/HOAC); 'H NMR 
(300 MHz, CD3CN) 6=1.8 (quintet, J = 7.0 Hz, 2H), 2.2 (t, J = 7.0 Hz, 4H), 2.9 (ABX, 
Jgem = 14 Hz, Jyic"^ = 6 Hz, = 7 Hz, 2H), 3.6 (s, 3H), 4.6 (bm, IH), 6.7 (d, J = 8 Hz, 
2H), 6.9(d, J = 8Hz, 2H). 
L-Tyrosine methyl ester hemiglutaramide NHS ester (22) 
Hemiglutaryl-L-tyrosine methyl ester (21) (60mg, 0.19 mmol) was suspended 
in 3.5 ml acetonitrile. The suspension became clear immediately after the addition of 
N-hydroxy-succinimide (66 mg, 0.57 mmol). It then turned to a suspension again after 
the addition of a solution of dicyclohexylcarbodiimide (126mg, 0.61 mmol) in 0.2 ml 
methylene chloride. The mixture was stirred at R.T. for 18 hours. After evaporation of 
the solvent, the residue was taken up in ethyl acetate and filtered to remove insoluble 
dicyclohexylurea and NHS. After removing solvent, 51 mg (64% yield) of white solid 
was obtained. Rf = 0.30 (6:1 EtOAc/hexanes); m.p. = 47-48 C; ^H NMR (300 MHz, 
CD3OD) Ô (ppm) = 1.99 (m, 2H), 2.29 (t, J = 7.2 Hz, 2H), 2.50 (t, J = 7.2 Hz, 2H), 
2.83 (s, 4H), 2.90 (dd, Jj = 7.8 Hz, = 5.3 Hz, IH), 3.11 (dd, = 13.8 Hz, = 5.3 
Hz, IH), 3.74 (s, 3H), 4.86 (dd, J; = 13.2 Hz, = 7.8 Hz, IH), 5.87 (bs, IH), 6.44 
(d, J = 8.1 Hz, IH), 6.72 (d, J = 8.4 Hz, 2H), 6.96 (d, J = 8.1 Hz, 2H); IR (neat) 3400, 
3302, 1811, 1782, 1734, 1663, 1516, 1205, 1072 cm'l. 
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N-(Boc-alanyl)-l-amino-l l-azido-3,6,9-trioxaiindecane (18). 
l-amino-l l-azido-3,6,9- trioxaundecane (17) (164.3 mg, 0.7528 tnmol) was dissolved 
in pyridine (0.80 ml) and added to a dry flask containing t-Boc alanine NHS ester (215.5 mg, 
0,7526 mmol). The solution was stirred under nitrogen. After an hour, TLC showed that t-
Boc alanine NHS ester was still present. After 3 hrs., the pyridine solvent was removed under 
vacuum and the crude product flashed on a 20 nrni x 8 in. silica gel column using 5% 
isopropanol in methylene chloride as eluent. The product was collected in 8 ml fractions from 
16-24 and, after removing solvent, a clear oil remained. 160.0 mg was collected but contained 
isopropanol in a 1:1 molar ratio as determined by NMR. The yield of product was 139.3 mg 
(48%). TLC: Rf = 0.3 (5% isopropanol in methylene chloride), IR: 2107.4,1709.7, 1668.0, 
1555.5 cnr\ ^H NMR (300 MHz, CDCI3): S = 6.6 (b.s., IH), 5.2 (b.s., IH), 4.18 (b.t., IH), 
3.73-3.61 (m, lOH), 3.58 (t, J= 5.4 Hz, 2H), 3.48 (t, J= 5.4 Hz, 2H), 3.41 (t, J= 4.9 Hz, 2H), 
1.46 (s, 9H), 1.36 (d, J= 6.8 Hz,.3H). 
N-Boc-alanyl-N*-biotinoyI-l,ll-diainino-3,6,9-trioxaundecane(19). 
N-(Boc-alanyl)-1-amino-ll-azido-3,6,9-trioxaundecane (18) (499.6mg, 1.283 mmol), 
dissolved in 4.9 mis EtOAc, was reduced to the free amine by the addition of360.6 mg (1.375 
mmol) triphenylphosphine and 50 ul water. Starting material was consumed after 4 hrs. as 
judged by TLC, which showed the appearance of a ninhydrin positive spot. The crude 
product, after removal of solvent, was used directly in the coupling with biotin NHS ester. Rf 
= 0.40 (Rf = 0.80 ft)r PhgPO biproduct) (5% NH4OH in EtOH). IR of the crude reaction 
mixture was consistent with the desired product and showed disappearance of the azide band 
at 2106 cm'l iH NMR(300 MHz, CDCI3) 5 = 1.36 (d, J = 7.01 Hz, 3H), 1.44 (s, 9H), 2.14 
(bs, IH), 2.89(t, J = 4.85 Hz, 2H), 3.56(t, J = 4.9 Hz, 2H), 3.65(m, 12H). 4.22(bs, IH), 
5.41 (bs, IH), 7.3-7.5(m, PhgPO byproduct). 
The amine obtained (466.4 mg, 1.283 mmol) and biotin NHS ester (441.3 mg, 1.293 
80 
mmol) were placed in a flask and dissolved in 4.0 mis distilled pyridine to give a clear solution. 
The solution was stirred under nitrogen overnight, after which time TLC showed that starting 
amine was completely gone. The crude mixture was flashed using a 30 mm silica gel column 
and 400 mil : 1 CH3CN; 15% MeOH/CHCIg followed by 400 ml 15% MeOH/CHCIg The 
desired product was collected in 76 % yield (323.4 mg) and was judged pure by NMR. TLC: 
Rf = 0.3 (15% MeOH/CHClg), NMR (300 MHz, CDCI3): Ô = 7.2 (b.s.), 7.0 (b.t.), 6.8 
(b.s.), 6.0 (b.s.), 5.6 (b.d), 4.5 (AB q., J= 4.84, 2.65, 4.88), 4.3 (AB q., J= 4.58, 2.26, 5.26), 
4.2 (b.t.), 3.9 - 3.5 (m), 3.4 (t, J= 4.8), 3.2 (q., J= 7.5, 3.7, 7.8), 2.9 (d of d, J= 4.86, 8.04, 
4.62), 2.2 (t, J= 7.5), 1.9-1.6 (m), 1.5 (s), 1.4 (d, J= 7.0). 
N-alanyl-N-biotmoyl-1,1 l-diamino-3,6,9-trioxaundecane hydrochloride (13HCI) 
19 (97,3 mg, 0,16 mmol) was dissolved in THF (3 ml) and HCl was then bubbled 
through the solution for 40 minutes. Evaporation of the solvent provided 13 as its 
hydrochloride salt in the form of a white foam. (84 mg, 100% yield). TLC: Rf = 0.5 (10% 
NH4OH in EtOH), »H NMR (300 MHz, CD3OD): 8= 1.51 (d, J = 7.0 Hz, 3H), 1.6-1.8 (m, 
6H), 2.26 (t, J = 7.3 Hz, 2H), 2.74 (d, J = 12.9 Hz, IH), 2.97 (dd, Jj = 12.9 Hz, = 4.89 Hz, 
IH), 3.2-3.3 (m, IH), 3.42 (t, J = 5.6 Hz, 2H), 3.55 (t, J = 5.4 Hz, 2H), 3,59 (2fs, J = 5.6 Hz, 
4H), 3.62-3.70 (m, 8H), 3,96 (q, J = 6.9 Hz, IH), 4.40 (dd, J; = 7.8 Hz, = 4.5 Hz, IH), 
4.58 (dd, J] = 7.8 Hz, J2 = 4.9 Hz, IH), Mass Spectrum (Electrospray, 1:1 H20:Me0H, 
positive ion) m/e = 490.3 (calculated 490.6) (M"*" - CI), 512.9 (calculated 512.6) (M"*" - HCl + 
Na). 
tert-Butyloxycarbonyl-L-alanine NHS ester (16) 
A solution of t-Boc-L-alanine (3.78 g, 20 mmol) and N-hydroxysuccinimide (2.3 g, 20 
mmol) in 25 ml THF was cooled in an ice water bath the dicyclohexylcarbodiimide (4.5 g, 22 
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mmol) dissolved in 10 ml THF was added slowly with stirring over a five minute period under 
nitrogen. Some white precipitate was formed after all of the DCC solution was added. The 
mixture was allowed to stand overnight at 0» C. The precipitated N,N'-dicycIohexylurea was 
removed by filtration and the solvent removed under vacuum. The crude solid was purified 
further through recrystallization from refluxing isopropanol to afford the product as a white 
soUd (4.25 g, 74% yield), m.p. = 165-1660 C (Literature m.p. = 167o C) NMR (300 MHz, 
CDCI3) 0=1.46 (s, 9H), 1.57 (d, J = 7.2 Hz, 3H), 2.84 (s, 4H), 4.7 (bs, IH), 5,07 (bs, IH). 
D-Biotin NHS ester (20b) 
D-(+)-Biotin and NHS were dried overnight over P^Og in vacuo. Biotin (118 mg, 0.48 
mmol) was dissolved in 3 ml DMF in a dried flask by gently heating at 80° C A solution of 
N,N*-carbonyldiiraidazole (78 mg, 0.48 mmol) in 0.7 ml DMF was then introduced to the 
flask. The mixture was stirred under nitrogen at 80° C for 30 minutes until CO2 evolution 
ceased and then at room temperature for 2.5 hours. The intermediate, biotinylimidazolide, 
came out of the solution as a flocculent white precipitate which was converted to the N-
hydroxysuccinimide ester by the addition of NHS (55.6 mg, 0.48 mmol) in 0.6 ml DMF. The 
mixture was then stirred at room temperature under nitrogen overnight. After removal of 
DMF under vacuum, recrystallization of the crude product from refluxing isopropanol 
provided the product as a white solid (115.5 mg, 73% yield). Rf=0.46(l:l CHClg/i-PrOH); 
m.p. = 199-2000 C (Literature m.p. = 2100 c)l4 Ih NMR (300 MHz, CD3OD) Ô = 1.58 (m, 
3H), 1.78 (m, 3H), 2.66 (t, J = 7.2 Hz, 2H), 2.70 (d, J = 14.1 Hz, IH), 2.83 (s, 4H), 2.93 (dd, 
J, = 12.9 Hz, J2 = 4.8 Hz, IH), 3.22 (m, IH), 4.32 (dd, Jj = 7.8 Hz, J2 = 4.5 Hz, IH), 4.49 
(dd, Ji = 7.8 Hz, J2 = 4.8 Hz, IH). 
82 
Azido acid (23) 
A mixture of azido alcohol (27) and diazide (28) (10.9916 g), determined to be 27.8 
% by weight azido alcohol (3.0891 g, 0.01409 mmol) by NMR, and potassium bromoacetate 
(5.62 g, 31.74 mmol) were weighed into a dry flask. Next, 6.0 ml DMF, which had been dried 
by storage over 4A molecular sieves, was added and stirring initiated. Powdered KOH was 
weighed out quickly and transferred to the flask under nitrogen and stirring was continued for 
two days at 45° C. After this time, 6 ml nanopure water was added and stirring was continued 
for an additional 12 hours at 45° C. 
The solvent was then removed under vacuum and the residue rinsed into a separatory 
funnel with 100 ml water and 50 ml methylene chloride. The layers were separated and the 
aqueous layer was extracted twice more with 50 ml methylene chloride (each time). The 
aqueous layer was then acidified with solid NaSO^ until the pH had been lowered to 2 and 
extracted thrice with 50-60 ml methylene chloride (each time). The methylene chloride 
extracts were dried over anhydrous sodium sulfate, filtered, and solvent removed to give a 
yellow oil. To ensure that all of the DMF had been removed, CCI4 was added and evaporated 
off three to four times. After placing the sample on the vacuum pump overnight, 3.5057 g 
remained which corresponds to 90% yield based on azido alcohol. NMR looked quite 
clean with no visible contaminant peaks. TLC showed one spot using 85:10:5 
CHCl3:MeOH:AcOH as eluent. NMR (300 MHz, CDCI3): ô = 4.15ppm (2 H, s), 3.7 ppm 
(14 H, m), 3.4 ppm (2 H, t, 6 Hz). FTIR 3399, 2909, 2107, 1748, 1123, 755 cm'k TLC(silca 
gel): Rf= 0.25 using 85:10:5 CHClg MeOH AcOH. 
Amino azide (17) 
The diazide (28) (3.0196 g, 12.36 mmol) was placed in a 250 ml flask and dissolved in 
55 ml ether. Next, 0.25 M H3PO4 was added. Triphenylphosphine (2.8196 g, 10.75 mmol) 
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was placed in a 25 ml addition funnel and dissolved in 20 ml ether. Rapid stirring was initiated 
and the solution of PhjP was added dropwise over a 10 minute period. The system was seated 
with a septum and balloon to prevent excessive evaporation of ether. During the course of the 
reaction, the balloon was observed to inflate, presumably due to nitrogen gas being liberated. 
After stirring for 24 hours, no triphenylphosphine was visible by TLC. 
The layers were then transferred to a separatory fUnnel using an additional 10 ml water 
and ether to rinse the flask and the ether layer removed. The aqueous layer was extracted 
twice more with 60 ml ether (each time). Next, the solution was covered with 10-15 ml ether 
and 12.8 g powdered NaOH was added. The addition generates heat and the solid initially 
dissolves, however, on cooling it precipitates from solution as a flocuiant white solid. This 
precipitate did not interfere significantly with the separations and the aqueous layer was 
extracted thrice with ether (50-60 ml each time) and twice with 40 ml methylene chloride 
(each time). The combined organic extracts were dried over anhydrous Na2S04, filtered, and 
solvent removed to give a clear oil. The product amino azide (1.8420 g, 8.44 mmol) was 
obtained in 79% yield based on PhgP and 68% yield based on starting diazide. NMR 
indicated that the product was quite pure except for the usual contaminant ofPhgPO (9:1 ). 
TLC showed one very heavy spot and another barely visible by ninhydrin. When spotted more 
lightly, the lower spot could not be seen. This observation was consistent with the previously 
determined >50:1 selectivity. The >50:1 selectivity was determined by HPLC. After making 
the aqueous solution containing amine 4M in NaOH, 100 ul benzylchloroformate was added. 
Two more 100 ul aliquots were added every 8 hours until amine was no longer visible by TLC 
using ninhydrin to visualize. The solution was extracted four times with distilled CH2CI2, 
dried over Na2S04, and solvent removed to give an oil. A 2-3 mg/ml solution was then 
prepared by dissolving the sample in HPLC eluent (1:1 CH3CN(0.05% TFA):H20(0.05% 
TFA)) and the samples were then analyzed by HPLC on a C-18 usorb-mv 4.6 x 100 mm 
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column, flow rate = 0.750 ml/min., X = 254 nm. Quantitation of the Cbz derivatives of the 
amino azide and diamine were performed by injecting 150 ul sample solution on a 20 ul 
sample loop. Amounts of amino azide and diamine Cbz derivatives eluting at 3.8 and 4.9 
minutes respectively were determined using response factors of the standard compounds. 
Response factors for the amino azide and diamine Cbz derivatives were 1.048 x 10* area/umol 
and 1.624 x 10* area/umol respectively. NMR (300 MHz, CDCI3): S = 1.9v (br. s, 2H), 
2.89 (t, J = 5.2 Hz, 2H), 3.40 (t, J = 5.0 Hz, 2H), 3.50 (t, J = 5.2 Hz, 2H), 3.55-3,80 (m, 
lOH); FTIR = 3415, 2912, 2106; TLC Rf = 0.55 using 10:90 NH4OH : ethanol as eluent. 
Coupling assay procedure 
1) Cut paper sample (25 or underivatized paper) into disks using a #2 cork borer and 
place in a foil well microtiter plate. 
2) Pretreat both derivatized and underivatized paper disks by incubating overnight in 
100 ul 0.1% Tween 20 in pH 7.4 PBS. 
3) Pipet ofFTween 20 solution and add reagents. 
a) Prepare a 72 mM stock solution of biotin-labelled alanine (13 HCI) in 65% 
CH3CN/ Na2C03 ^ as follows; 
- Transfer 15.0 mg (29.1 umol) 13-HCI to a tared vial. 
- Add 100 ul H2O, 200 ul CH3CN, and 7 ul saturated Na2C03 (to 
make pH 8-9). 
- Add 35 ul H2O and 63 ul CH3CN. 
The solution at this point should be a single phase. If two phases are present, the salt 
concentration is probably too high. Add more water until one phase is obtained. 
b) Prepare a 420 uM chymotrypsin solution in PBS by dissolving 5.32 mg (210 
umol) chymotrypsin in 0.500 mis PBS. 
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c) Transfer 50 ul of the 13-HCl stock solution to each of five test tubes. 
d) Add 100 ul of chymotrypsin stock solution to a test tube containing 100 ul 
PBS. Mix by pipetting up and down 15 times. Transfer 50 ul of this solution into the next test 
tube which contains 150 ul PBS, mix, and repeat three more times. Five solutions are obtained 
with concentrations of210, 52.5, 13.1, 3.28, and 0.82 uM, 
e) Add 5 ul of the diluted chymotrypsin solution to a test tube containing 50 ul 
13 HC1 stock solution and mix. Five reagent solutions are obtained with [13 HC1] = 65.4 mM 
and [chymotrypsin] = 19.1, 4.80, 1.19, 0.298, 0.0746 uM. The CH3CN % = 59 %. These 
solutions should be prepared just before use as chymotrypsin is unstable under the conditions. 
Preparation time from first solution to fifth solution was approx. 3 min. 30 sec.. 
f) Place 5 ul of 19.1 uM CT in B2, D2, F2, G2, G3, D11, and B11. 
4.80 " B3, D3, F3. 
1.19" B4,D4,F4. 
0.298 " B5, D5, F5. 
0.075 " B6, D6, F6. 
Place 5 ul of 72 mM 13-HCl in 65% CH3CN in B8 and B9. 
Place 5 ul of 210 uM CT in D9, F8, and F9. 
The paper absorbs most of the liquid. The plate was vortexed for 2 min. and 30 sec. 
after all additions were complete. 
4) Rinse with 1% SDS in nanopure H2O being careful not to cross contaminate in 
early rinses. Rinse five times, transfer paper, then rinse five more times with SDS and three 
times with nanopure H2O. 
5) Block with 200 ul 3% BSA in PBS for 1 hr. 15 min. at 37 C. Pipet off 
6) Add 50 ul streptavidin-HRP diluted 1:6000 in 3% BSA/PBS. Incubate 30 min. at 
37 C and pipet off 
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7) Rinse twice with PBS, nine times with 0.1% Tween 20 in PBS, and three times with 
nanopure H2O. 
8) Add 100 ul ABTS developer (2.4 mg ABTS + 6.0 mis citrate + 3.6 H2O2). 
Develope for 20 min. and read absorbance at 405 nm subtracting 630 nm. 
CT = Chymotrypsin (Sigma), A = biotin-labelled alanine ( JWL-4-075), 
T = tyrosine derivatized paper (JWL-4-127), P = underivatized paper, 
D = dialysis tubing. 
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PAPER m 
USE OF BIOTINYLATED 7-AZATRYPTOPHAN 
AS A PROBE OF SMALL MOLECULE-PROTEIN INTERACTIONS 
91 
INTRODUCTION 
The utility of 7-azattyptophan as an alternative to tryptophan for optically probing 
protein structure and dynamics is demonstrated by investigating the complex of egg-white 
avidin and biotinylated 7-azatryptophan. We report the synthesis of biotinylated 7-
azatryptophan and optical measurements of its complexation with avidin. Although there are 
four biotin binding sites, the emission from the 7-azatryptophan tagged to biotin decays 
according to a single exponential, whereas the tryptophyl emission from avidin requires at 
least three exponentials in order to be adequately fit. Fluorescence depolarization 
measurements of the complex probed by emission from 7-azatryptophan reveal both rapid 
(~50 ps) and much longer-lived decay. The former component is attributable to the local 
motion of the probe with respect to the protein; the latter component represents overall 
protein tumbling. 
The Petrich group has proposed the nonnatural amino acid, 7-azatryptophan, as an 
alternative to tryptophan as an optical probe of protein structure and dynamics'"' ^ The 
merits of 7-azatryptophan lie in its intrinsic single exponential fluorescence decay in 
water''^''® as compared to the nonexponential decay exhibited by tryptophanas well as 
in its spectroscopic distinguishability with respect to tryptophan in both absorption and 
emission^'^-'V This allows measurement of rapid motions of the 7-azatryptophan side chain 
in the presence of other tryptophan residues. Furthermore, 7-azatryptophan can be 
incorporated into bacterial protein and is amenable to peptide synthesis'-^. An important 
application of 7-azatryptophan is the incorporation of it into small peptides, its binding to 
cofactors, and subsequent investigatation of the dynamics of these smaller, tagged molecules 
bound to the target protein of interest. In this article, we demonstrate the feasibility of this 
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approach by studying biotinylated 7-azatryptophan (inset of Figure 1) bound to avidin. 
Avidin is a tetrameric protein found in avian egg white. Each subunit contains 128 
residues of which 4 are tryptophan. Avidin is believed to function as an antibacterial agent 
through its ability to reduce the free concentration of biotin. The dissociation constant of the 
avidin-biotin complex is about 10"^^ The essentially irreversible binding afforded by 
this complex and the ready modification of the carboxylate group of biotin have permitted the 
study of the interactions of several biotin adducts with avidin. Examples are the interactions 
of biotin lipids^' and biotinylated asparagine-oligosaccharides^^ with avidin and streptavidin. 
Recently, x-ray structures of egg-white avidin and its complex with biotin have appeared^'^. 
Biotin is shown to bind in a B-barrel constructed from eight antiparallel 3 strands. The 
tryptophan residues 70 and 97 form part of the avidin binding site and are anchored through 
hydrogen bonds to other residues, thus stabilizing the binding site. The bicyclic ureido ring of 
biotin forms hydrogen bonds with Asn-12, Ser-16, Tyr-33, Thr-35, Asn-118, and possibly 
Thr-77 24. 
We have prepared a biotin-7-azatryptophan adduct in order to demonstrate further the 
spectroscopic distinguishability of 7-azatryptophan from tryptophan and to investigate the 
mobility of the 7-azatryptophan moiety in the complex. 
The research description that follows was a collaboration between myself, under the 
guidance of Dr. Alan Schwabacher, and researches in Dr. Jacob Petrich's group namely, R. 
Rich and F, Gai. They had previously studied the use of 7-azatiyptophan as a fluorescent 
probe and it was my role in this collaboration to synthesize the key compound for the 
fluorescence studies which was biotin-labeled 7-azatryptophan methyl ester. I was chosen for 
this project due to my familiarity with the properties and characterization of biotinylated 
derivatives. As very sensitive fluorescence measurements would be used to study the binding 
of biotin-labeled 7-azatryptophan to avidin, it was necessary to prepare a very pure sample of 
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this derivative. Any underivatized 7-azatiyptophan contaminating the sample would remain in 
solution at any concentration of avidin leading to a different fluorescence spectrum and 
conflicting results. The sample which I prepared was twice recrystallized and well 
characterized as described below. 
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RESULTS AND DISCUSSION 
Biotinyiated 7-azatryptophan methyl ester 1 was synthesized beginning with d,l-7-
azatryptophan. The methyl ester was prepared by dissolving the amino acid in methanol and 
subsequent addition of thionyl chloride. The crude ester could then be purified through 
recrystallization from methanol and ether to afford the dihydrochloride salt in 74% yield. The 
7-azatryptophan methyl ester was then treated with biotin NHS ester (prepared as described in 
the previous chapter) in pyridine to acylate the a-amino group and form the desired product 2 
which was then twice recrystallized from chloroform and methanol in 49% yield. Elemental 
O H  
MeOH 
H C I  
NHS 
Î 
HN'^NH 
Py 
O  H O  
analysis and NMR were both consistent with a crystal form incorporating one mole each of 
chloroform and methanol. 
Figure 1 displays the fluorescence spectrum of avidin, the biotin-7-azatryptophan 
adduct, and the complex of the biotin-7-azatryptophan adduct with avidin. Figure 2 
demonstrates that with an excitation wavelength of 310 nm, 7-azatryptophan is detected 
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predominantly in the complex. 
Figure 3 presents the fluorescence anisotropy decay of the biotinylated 7-
azatryptophan; Figure 4, of avidin alone. Figure 5 presents the fluorescence anisotropy decay 
of the complex of biotinylated 7-azatryptophan with avidin. Even in the presence of 16 
tryptophan residues, the 7-azatryptophan is detected unambiguously. The fluorescence 
anisotropy decay of the avidin-biotin complex that is detected by means of the 7-
azatryptophan chromophore is clearly different from that observed from avidin itself (detected 
by means of the tryptophyl residues). 
The fluorescence lifetime of biotinylated 7-azatryptophan is dominated by emission 
from 7-azatryptophan and is well described by the function: K(t) = 0.96exp(-t/639 ps) + 
0.04exp(-t/2550 ps). The residual 4% of this fluorescence decay is attributed to biotin itself, 
which is characterized by a fluorescence lifetime with a long component of about 3 ns. 
The complex of avidin and biotinylated 7-azatryptophan is flt well to a double-
exponential fluorescence decay. The dominant component is again attributed to 7-
azatryptophan and has a time constant of 610 ps. Because the Petrich group had chosen a 3-
ns full-scale time base to investigate the rapid dynamics, they consequently have not made a 
very precise determination of either the magnitude or the duration of the longer-lived 
component, which arises mostly from tryptophan itself but contains a small contribution from 
biotin. Fitting the data collected on a full scale of 3 ns indicates that about 85% of the 
emission collected arises from 7-azatryptophan. 
Using the steady-state absorption and emission spectra, the Petrich group could then 
calculate the amount of longer-lived component that ought to be expected in the time-resolved 
measurements. We assume that SavidinP^O nm) = 1600 cm"^ M"' since 8Xip(310 nm) = 100 
cm"' M ! 3 and there are 16 tryptophans in the protein. We also know^ that S7.q7^^rp(310 
nm) = 1100 cm"' M"'. If the steady-state fluorescence spectra of avidin itself and the complex 
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of avidin and biotinylated 7-azatryptophan are scaled according to their fluorescence quantum 
yields (or their average fluorescence lifetimes) and the extinction coefficients at 310 nm, and if 
these scaled spectra are integrated starting at 400 nm, we find that about 7% is expected to 
arise fi-om tryptophan itself, in good agreement with the estimate from the fluorescence 
lifetime measurements. 
Detection of emission wavelengths redder than 400 nm was chosen to accelerate the 
data collection time and to ensure discrimination against emission from tryptophan itself Of 
course, the "homogeneity" of the 7-azatryptophan signal could have been improved by 
selecting a emission wavelength at even lower energies as a cutoff The important conclusion 
to be drawn from these experiments is that even in the presence of a small amount of emission 
from a substance that is not 7-azatryptophan, the interpretation of our results will not be 
hindered because we know the identity of this substance. 
The steady-state absorption and fluorescence properties of 7-azatryptophan are 
sufficiently different from those of tryptophan that selective excitation and detection may be 
effected. The absorption maximum of 7-azatryptophan is red shifted by 10 nm with respect to 
that of tryptophan. There is also a significant red shift of about 50 nm of the maximum of the 
fluorescence spectrum of 7-azatryptophan with respect to that of tryptophan. We have 
measured the fluorescence decays of mixtures of tryptophan and 7-azatryptophan. Only when 
the ratio of tryptophan to 7-azatryptophan is as great as 10:1 does the tryptophyl emission 
become detectable. Furthermore, as opposed to aqueous tryptophan at pH 7, the fluorescence 
decay of 7-azatryptophan is single exponential. This result holds across the emission band and 
over the pH range we have studied, from 4 to 13. The monoexponential fluorescence decay in 
itself indicates the enormous preference for using 7-azatryptophan instead of tryptophan as a 
fluorescent probe. 
Recently, there have been reports suggesting that 5-hydroxytryptophan is a useful 
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biological probe as welP^. While in some cases 5-hydroxytryptophan may prove useful (if 
relatively long excitation wavelengths, ~320 nm, are employed), we have demonstrated^® that 
because its fluorescence spectrum and lifetime are similar to those of tryptophyl 
chromophores, it can be more difficult to distinguish from tryptophan than is 7-azatryptophan. 
This is due in large part to the 3.8-ns lifetime of S-hvdroxytryptophan. which is similar to that 
of the long component of tryptophan. In mixtures of 5-hydroxytryptophan and the tryptophyl 
chromophore, NATA (N-acetyl tryptophanamide), in a ratio as high as 1/10, the presence of 
5-hydroxytryptophan cannot be discriminated from the mixture ( ex ~ ^05 nm; ^ nm), 
On the other hand, when the ratio of 7-azatryptophan to NATA is as low as 1/40, the 7-
azatryptophan is easily detected*®. 
The spectroscopic distinguishability of 7-azatryptophan in the presence of avidin is 
demonstrated clearly in all of the Figures. As is noted above and in the caption to Figure 5, 
about 85 % of the emission of the complex ofbiotinylated 7-azatryptophan with avidin is 
attributable to 7-azatryptophan. More importantly, the emission attributable to 7-
azatryptophan decays according to a single exponential even though there are four biotin 
binding sites in avidin. On the other hand, as indicated in the caption to Figure 4, the 
fluorescence decay of avidin itself requires at least three exponentials in order to be adequately 
fit. This is not surprising considering that there are 16 tryptophans present and taking into 
account the intrinsic nonexponential fluorescence decay of tryptophan. 
The fluorescence anisotropy decay ofbiotinylated 7-azatryptophan in complex with 
avidin is fit well to two exponentially decaying components, the second of which is very long 
lived: r(t) = ri(0)exp(-t/Ti) + r2(0)exp(-t/T2) = 0,08exp(-t/47 ps) + 0.15 (Figure 5). That the 
fluorescence anisotropy is fit to two exponentials indicates that we are probing the rapid 
librational motion of the 7-azatryptophan probe with respect to avidin as well as the overall 
tumbling motion of the avidin itself For probes attached to globular proteins, the order 
98 
parameter, S^, is a model independent measure of the extent to which restricted motion can 
occur26, s2 = [r(t)/r(0)] exp(t/Tr) = r(0+)/rgg(0). and r(0+) are determined by the fit of the 
long-time behavior of the anisotropy decay (the overall protein reorientation or tumbling) to a 
single exponential and are equivalent to Xi and r2(0), respectively. rgg(0) is the initial value of 
the anisotropy less those nonmotional factors contributing to the anisotropy decay^^. In the 
treatment of the data, rgg(0) = ri(0) + r2(0). gives an indication of the magnitude of the 
depolarizing motions that are present in addition to the overall protein reorientation. Thus a 
value of < 1 implies local motion of the chromophore with respect to the body of the 
protein, and = 1 implies a rigid chromophore that undergoes depolarization only by means 
of overall protein motion. The order parameter can be related to a hypothetical cone 
semiangle, Gq, within which the transition dipole moment can diffuse^^'^®: S = 1/2 cosGq (1 + 
cosGq). In this example, Gq = 57°. The large value for the cone semiangle indicates that 
while the biotin itself is firmly attached to the avidin, the 7-azatryptophan tag lies either in a 
very mobile part of the protein or actually remains exterior to the protein. The latter of these 
possibilities is more likely given the large contribution of the rapid component of the 
anisotropy decay and the similarity of the fluorescence spectrum of 7-azatryptophan in the 
complex (Figures 1 and 2) to 7-azatryptophan in water^'^®. If 7-azatryptophan were buried in 
the protein interior, not only would the rapid component be less pronounced (or absent) but 
its fluorescence spectrum would be expected to resemble more closely what is observed in 
pure alcohols. In alcohols, a second maximum is observed at lower energies. This second 
band arises fi*om excited-state tautomerization2'5,8,31^ which does not occur to any significant 
extent either in pure water* or in the complex studied here. 
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CONCLUSIONS 
1. Fluorescence anisotropy measurements of the complex of biotinylated 7-
azatiyptophan with biotin demonstrate that 7-azatryptophan is a powerful probe of small 
molecule-protein interactions owing to its spectroscopic distinguishability with respect to 
tryptophan and to its intrinsic single-exponential fluorescence decay. 
2. Biotinylated 7-azatryptophan binds tightly to avidin (as demonstrated by 
chromatography), but the 7-azatiyptophan moiety enjoys substantial mobility and can be 
modelled as diffusing in a cone with a half angle of 57". 
3. The four avidin binding sites provide equivalent environments as indicated by 
the fluorescence lifetime and anistropy decay of the bound biotinylated 7-azatryptophan. 
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EXPERIMENTAL 
dl-7-azatryptophan methyl ester dihydrochloride (1) 
dl-7-azatryptophan (229.4 mg, 1.028 mmol) was placed in a dry flask and suspended 
in 4.5 mis methanol. Thionyl chloride (980 ul, 13.6 mmol) was added slowly, the flask was 
sealed and the resulting solution was stirred. After about 1/2 hour, a large amount of white 
precipitate came out of solution. An additional 5 mis methanol was added and the solution 
was heated briefly. This dissolved the solid. Stirring was continued for 12 hours and after this 
time the reaction was judged to be complete by TLC. Solvent was removed under vacuum and 
the residue was recrystallized from methanol and ether. 1st crop = 220,3 mg, 74% yield. 
White crystals. M.P. = 214-2160 c iR NMR (300 MHz, CD3OD): d = 8.82 (d, J = 7.8 Hz, 
IH); 8.50 (d, J= 5.8 Hz, IH); 7.75 (s, IH); 7.66 (dd, = 6.1 Hz, Jg = 7.7 Hz, IH); 4.49 (t, J 
= 6.4 Hz, 1 H); 3.83 (s, 3H); 3.64-3.49 (m, 2H) Rf on TLC: 0.66 on silica gel using 1:9 
NH^OHiethanoI as eluent and ninhydrin or UV to visualize. Fluoresces at 354 nm. 
N-a-Biotinoyl-DL-7-azatryptophan methyl ester (2) 
Biotin N-hydroxysuccinimide ester (100 mg, 0.302 mmol) and D,L-7-azatryptophan 
methyl ester dihydrochloride (71.2 mg, 0.245 mmol) in 3.0 mL pyridine (distilled from 
ninhydrin) were stirred under N] for 19 hr. The pyridine was removed under vacuum at 40°C 
and the residue was suspended in approximately 30 mL of ethyl acetate and extracted three 
times with 50% saturated aqueous NaHCO], and once with saturated NaCl. The ethyl acetate 
layer was then dried over Na2S04, decanted, and the solvent was removed to yield 90 mg 
(83% yield) of product as a white solid. An analytical sample was obtained by recrystallization 
from methanol and chloroform (53 mg, 49%, MP = 220-222°C). ^H NMR(300 MHz, 
CD3OD): Ô = 8.07 (d, 4.78 Hz, 1 H); 7.92 (d, 7.87 Hz, 1 H); 7.81 (s, IH); 7.01 (dd, 4.84 
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Hz, 7.83 Hz, 1 H); 4.66 (m. 1 H); 4.39 (m, 1 H); 4.12 (m, 1 H); 3.59 (s, 3 H); 3.09-2.97 
(m, 2 H); 2.82 (dd, 4.89 Hz, 12.72 Hz, 1 H); 2.59 (d, 12.73 Hz, 1 H); 2.09 (t, 6.93 Hz, 2 
H); 1.62-1.39 (m, 6 H). IR(KBr): 1735, 1699, 1536, 1655 cm" 1 Anal: calcdfor 
C2iH27N504S(CHCl3)i(CH30H)i, C 46.28%, H 5.40%, N 11.73%; found, C 46.54%, H 
5.39%, N n.55%. 
Initially, proton NMR in CD3OD indicated that both methanol and chloroform were 
present in a 1:1 ratio with 2. However, after removal of the deuterated solvent under vacuum 
and redissolving in CD3OD, proton NMR indicated that methanol and chloroform were no 
longer present. This observation is consistent with methanol and chloroform being 
incorporated into the crystal structure of 2. 
Samples used in fluorescence studies were dissolved in a 95/5 H20/methanoi mixture. 
The small amount of methanol was necessary to dissolve the biotinylated 7-azatryptophan. No 
degradation of avidin was observed at this concentration of methanol. Affinity-purified, egg-
white avidin was obtained from Sigma and used without further purification. Since avidin has 
four biotin binding sites, the complex was prepared in the ratio of 4 biotinylated 7-
azatryptophan molecules to 1 avidin molecule. The concentration of avidin was determined 
spectrophotometrically using 6(282 nm) = 24,000 cm"^ M"' Binding of the biotin-7-
azatrvptophan complex to avidin was verified bv chromatopraphv. 
Spectroscopic measurements 
Fluorescence lifetimes, K(t), and fluorescence anisotropy decays, r(t), were obtained 
using the time-correlated, single-photon counting technique^'^'^. Parallel and perpendicular 
emission intensities for measurements of anisotropy decays were collected alternately with a 
rotating analyzer polarizer in order to obviate scaling procedures^. The full-scale time base 
for all lifetime and anisotropy measurements was 3 ns in order to measure accurately the rapid 
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component of the anisotropy decay. Consequently, long-time depolarizing events (which are 
not the primary concern of this work) were not fully characterized. All measurements of the 
4:1 biotinylated-7-azatryptophan:avidin complex were performed with = 310 nm and 
^em ^ 400 nm to minimize the detection of emission from tryptophan residues within the 
protein. All other measurements were performed with = 285 nm and A,em ^ 320nm. 
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FIGURE CAPTIONS 
Figure I. 
Fluorescence spectra of (a) avidin (Xen,"^ = 339 nm); (b) biotinyIated-7-
azatryptophan = 390 nm), whose structure is displayed in the inset; and (c) the 
complex of avidin and the biotinylated 7-azatryptophan. = 310 nm. 
Figure 2. 
Fluorescence spectra of the complex of avidin and biotinylated 7-azatryptophan (1 per 
binding site) as a function of excitation wavelength. Note that at Xgx = 3I0 nm essentially 
only emission fi'om 7-azatryptophan is observed whereas at bluer excitation wavelengths the 
contribution from tryptophan in avidin is more pronounced. 
Figure 3. 
Parallel and perpendicular fluorescence intensity profiles from which the anisotropy 
decay is calculated [6] for biotinylated 7-azatryptophan: = 285 nm, > 320 nm, 20°C. 
The fluorescence anisotropy decay was fit to a single exponential: r(t) = 0.09exp(-t/60 ps), 
= 1 .SO. Displayed above the polarized fluorescence profiles are the residuals for the parallel 
and the perpendicular emission, respectively. The fluorescence lifetime of this compound was 
fit to the function; K(t) = 0.96exp(-t/639 ps) + 0.04exp(-t/2550 ps), = 1.27. The residual 
contribution of long-lived component is due to biotin itself, which is weakly fluorescent. 
Biotin has an average fluorescence lifetime of 1.5 ns (and a long-lived component of about 3 
ns) in a 95/5 water/methanol mixture. The values of the limiting anisotropies, r(0), reported 
here and in Figures 4 and 5 are consistent with steady-state measurements obtained in glasses 
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[6,29,30]. The upper set of residuals corresponds to emission polarized parallel to the 
excitation source; the lower, perpendicular to the excitation source. 
Figure 4, 
Parallel and perpendicular fluorescence intensity profiles from which the anisotropy 
decay is calculated for avidin: = 285 nm, > 320 nm, 20°C. The fluorescence 
anisotropy decay was fit to a single exponential; r(t) = 0.1 lexp(-t/3.97 ns), = 1.25. The 
fluorescence lifetime of avidin was fit to the function: K(t) = 0.43exp(-t/53 ps) + 0.37exp(-
t/498 ps) + 0.20exp(-t/2360 ps), = 1.16. The upper set of residuals corresponds to 
emission polarized parallel to the excitation source; the lower, perpendicular to the excitation 
source. 
Figure 5. 
Parallel and perpendicular fluorescence intensity profiles from which the anisotropy 
decay is calculated for the complex of avidin and biotinylated 7-azatryptophan (1 per binding 
site), Xgx = 310 nm, > 400 nm. As indicated in the Results section, more than 80% of the 
emission comprising the anisotropy decay is due to the 7-azatryptophan chromophore. The 
anisotropy decay is well described by two components: r(t) = 0.08exp(-t/47 ps) + 0.15; = 
1.30. The second component of the anisotropy decay reflects the overall tumbling of the 
protein itself and is too long-lived to be accurately determined on a 3-ns time scale, on which 
it appears to be infinite. The upper set of residuals corresponds to emission polarized parallel 
to the excitation source; the lower, perpendicular to the excitation source. 
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GENERAL SUMMARY 
In this thesis, the development of a general assay for the detection of coupling 
catalysts at low concentration has been discussed. In operation, the assay is quite similar to 
the ELISA used to detect antibody binding, and as a result, should be quite easy to carry out 
using existing materials and techniques. Such an assay is timely in light of the continuing 
advances in antibody production through combinatorial approaches. Production of catalytic 
antibodies has been limited by the ability to efficiently screen the large pool of potential 
catalysts directly for catalytic activity and it is hoped that the assay developed here will be of 
great utility in streamlining this process. 
Although our attempts to obtain a catalytic antibody for peptide ligation was 
unsuccessful, the potential for the assay has been demonstrated by the detection of peptide 
coupling catalyzed by solvent-damaged a-chymotrypsin at extremely low levels. The activity 
of the enzyme under these conditions is comparable to that observed for first generation 
catalytic antibodies and, as a result, this system provides a good model. 
One factor contributing to the high sensitivity of the assay is the extremely large 
association constant between avidin and biotin. This property has also been taken advantage 
of by attaching biotin to 7-azatryptophan the latter of which serves as a fluorescent probe 
owing to its unique excitation and emmision spectra. The biotin tag causes 7-azatryptophan to 
be held in close proximity to the protein avidin and by monitoring changes in the emission 
spectrum of 7-azatryptophan, information has been obtained about the motional constraints 
felt by small molecules near the surfaces of proteins. 
Connectors capable of linking two molecules of interest together are in great demand 
by researchers in a variety of fields who wish to perform labeling studies or studies involving 
molecules tethered to surfaces. Through my research, I have also worked out methods for the 
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large-scale production of biflinctionai linkers which have been found useful for the purposes 
described above. The linkers are complementary in nature, one being an amino acid analog 
white the other is a monoprotected diamine. The linkers have the desirable properties of being 
long and flexible and have been found to increase the solubility of the conjugates formed 
relative to the corresponding hydrocarbon analogs. It is my help that these linkers will find 
continued use in a variety of applications. 
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